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ABSTRACT OF DISSERTATION

AN EXAMINATION OF THREE TRANSITIONAL EVENTS IN THE SUBSTANCE
MISUSE TRAJECTORIES OF WOMEN WITH CRIMINAL LEGAL SYSTEM
INVOLVEMENT
Research has consistently demonstrated that criminal legal system (CLS)-involved
women are distinct from men in initiation and course of drug use, with important
differences on biological, environmental, and sociocultural levels. Thus, the unique
pathways and transitions into and out of drug use for women with CLS involvement are
critical to consider from a research perspective, but also from a need to develop and support
evidence-based, women-centered services in correctional contexts. This dissertation
project uses a three-paper format to investigate three aims: (1) to understand CLS-involved
women’s initiations to injection drug use and their experiences providing injection
initiation assistance (IIA) to others; (2) to explore unique correlates of CLS-involved
women’s experiences with overdose and overdose reversal, including relationships
between overdose and traumatic stress; and (3) to examine community reentry and
recurrences of drug use post-incarceration for women who have completed correctionsbased substance use treatment services.
This project utilizes secondary data from two studies. Aim 1 includes crosssectional data from the Women’s Intervention to Stop HIV/HCV, conducted with women
incarcerated in rural Appalachia. Aims 2 and 3 use data from the Criminal Justice Kentucky
Treatment Outcome Study (CJKTOS), a longitudinal state-funded evaluation of
corrections-based substance use treatment in Kentucky. Aim 2 is conducted using baseline
CJKTOS data collected from women at treatment entry, describing their experiences
during the 12 months prior to incarceration. Aim 3 uses a mixed-methods analysis of
follow-up CJKTOS data collected from a stratified random sample of women who
graduated from corrections-based treatment, 12 months after their release to the
community.
Collectively, findings from the three papers contribute to a complex portrait of
factors that are associated with CLS-involved women’s risk of substance misuse-related
harm. Specifically, findings from Aim 1 suggest that women who exhibit trajectories of
drug use characterized by faster transitions and more severe patterns, and who are more
enmeshed in social networks of others who use drugs, are more likely to have provided

IIA. Results from Aim 2 indicate that witnessing and/or experiencing overdose is common
among treatment-seeking incarcerated women and independently associated with mental
health issues, although knowledge of where to obtain naloxone is also related to lower odds
of meeting PTSD criteria among women who have witnessed overdose. Finally, findings
from Aim 3 show that, across factors at all social ecological levels, employment
demonstrates the strongest relationship to abstinence from drug use after release from
incarceration. However, women’s qualitative appraisals of risk and protective factors
emphasized internal/individual qualities (e.g., motivation), complex relational influences,
and environmental triggers as critical for recovery.
The use of multilevel theoretical models to guide selection of variables across all
three papers emphasizes the need to frame substance misuse transitions not just from an
individual-level perspective, but also from interpersonal, community, and intersectional
standpoints. Implications for prevention, intervention, and recovery support services for
CLS-involved women are also discussed, as well as the value of comparing quantitative
findings alongside women’s subjective understanding of events.
KEYWORDS: women, incarceration, substance use disorder, overdose, injection drug
use, addiction
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CHAPTER 1. BACKGROUND AND INTRODUCTION
1.1

An introduction to the topic
Illicit drug use is a prevalent issue in the United States (U.S.), with 59.3 million

people reporting past-year drug use and 18.4 million meeting past-year criteria for a
substance use disorder (SUD) for any illicit drug (CBHSQ, 2021), as defined by the
Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5; APA,
2013). Nationally representative U.S. data indicate that drug use remains more prevalent
among men than women, by lifetime (55.9% vs. 50.2%), past year (24.2% vs. 20.3%),
and past month (15.7% vs. 12.6%) measures, although these gender gaps in substance use
and SUD in the U.S. continue to narrow (CBHSQ, 2021; Pitel et al., 2010). Additionally,
the gender gap is reversed among individuals involved in the criminal legal system
(CLS), with a greater proportion of incarcerated women than men reporting recent use or
meeting diagnostic criteria for SUD (Bronson et al., 2017), even in international samples
(Fazel et al., 2017). Among U.S. individuals incarcerated in prisons, 50.8% of women
are estimated to meet SUD criteria for illicit drugs, compared to 38.5% of men
(Maruschak et al., 2021). Although U.S. prisons house almost twice as many
incarcerated persons as jails at any given time (54.8% vs. 28.8% of the incarcerated U.S.
population), jails experience much higher population turnover, with 17 times the number
of admissions per year (Sawyer & Wagner, 2022), and past estimates of SUD prevalence
among women in jail settings suggest even higher rates than observed in prison (Bronson
et al., 2017; Swavola et al., 2016).
Women, particularly those with a history of substance misuse, often enter the CLS
with biopsychosocial histories that create heightened risk for adverse outcomes. For
1

example, women in jail or prison are more likely than their male counterparts to report
both serious psychological distress and a history of mental health disorder diagnosis
(Bronson & Berzofsky, 2017), experiences of trauma (James & Glaze, 2006; Lynch et al.,
2011), and a history of chronic health conditions and infectious diseases (Maruschak et
al., 2016). These factors may be interdependent with drug use, such that use of drugs
may make women more vulnerable to victimization or infectious disease transmission,
but women with experiences of trauma, physical pain, or mental distress may also use
drugs for numbing or coping purposes.

1.2

Women’s drug use and criminal legal system (CLS) involvement
Although global leaders have called for a public health rather than a penal

approach to addressing drug use disorders (Volkow et al., 2017; Volkow, 2021), most
intoxicating substances are currently illegal, and thus drug use and CLS involvement are
often overlapping experiences. Indeed, about one-fourth of women and girls incarcerated
in the U.S. are held on drug offenses (Kajstura, 2019). However, various criminological
theories have proposed further intersections of drug use and crime. For example,
Goldstein’s (1985) conceptual framework of the drugs/violence nexus proposes that drug
use is linked to violent crime and risk of victimization by three possible pathways: 1)
psychopharmacological, wherein the effects of intoxication or withdrawal increase the
likelihood of violence; 2) economic-compulsive, wherein crime is committed to support
costly drug use; and 3) systemic, describing “traditionally aggressive patterns of
interaction within the system of drug distribution and use” (p. 497). Bennett and
Holloway (2009) have refined Goldstein’s tripartite framework to encompass a larger
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scope of drug-related crimes, also acknowledging the bidirectional influence between
drug use and illegal behavior.
Canadian and Australian researchers have attempted to quantify this relationship
through measurement of “attributable risk,” asking incarcerated individuals to self-report
whether their crime was committed to support their substance use, or if they would not
have committed their crime had they not been under the influence of drugs or alcohol at
the time. Young and colleagues (2021) found that 26% of violent crimes and 25% of
non-violent crimes in Canada from 2006-2016 (excluding drug-related charges) were
attributable to illicit drug use. Australian researchers examined these attributions
separately by gender and found that a greater proportion of incarcerated women (31%)
attributed their current offense to intoxication or addiction to illicit drugs, compared to
men (18%; Johnson, 2004). Thus, drug use and CLS involvement often co-occur, but are
also theoretically intertwined, even causally related, experiences. However, these
differences between men and women emphasize the need for gendered experiences to be
centered in discussions of individual trajectories in drug use and crime, which has
important implications for treatment and supportive services, especially those offered in
CLS contexts.
Acknowledging the limitations of many existing criminological theories,
gendered pathways frameworks are part of a feminist criminological tradition which
posits that theories of crime “must account for the myriad ways that gender matters”
(Chesney-Lind & Pasko, 2012, p. 22). A pathways perspective emphasizes that a
woman’s trajectory of criminal behavior is often shaped by, and intertwined with, abuse,
victimization, mental health issues, dysfunctional intimate relationships, and a lack of
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human, financial, and social capital (Leverentz, 2014; Visher & Travis, 2003; Wesely &
Dewey, 2018). Although often unacknowledged in gendered pathways discourse, the
intersectional influence of structural and systemic racism on the health, service access,
financial opportunities, and criminalization of women of color must also be
acknowledged as profoundly impactful for CLS exposure and experiences (Bailey et al.,
2021; Bonilla-Silva, 1997; Powell & Phelps, 2021). Other social factors such as rurality
(Sutherns, 2005) or sexual orientation (Logie, 2012) have a further critical impact on
women’s social environments and supports, access to services or opportunities, and
health risks/needs, which in turn may shape pathways to criminality. Critically, the same
criminogenic factors emphasized in pathways frameworks are also key contributors to
women’s illicit drug use, which can itself increase risk of criminal behavior, creating a
network of reinforcing disadvantage (Salisbury & Van Voorhis, 2009).
Examining criminality and substance use through a gendered pathways
framework also emphasizes the longitudinal nature of both issues, as over time women
experience different states of severity of problematic drug use (e.g., SUD) and criminal
behavior. The process of pursuing recovery from SUD – resolving drug-related
problems, healing wounds, managing ongoing vulnerabilities, and developing a “healthy,
productive, and meaningful life” (p. 236, White, 2007) – is a complex endeavor.
Furthermore, given the interrelated nature of drug use and crime (for many women) –
wherein drug use is associated with criminal behavior, criminality may reinforce drug
use, and certain conditions or factors are associated with both – resolution of drug userelated issues may also support women’s desistence from crime. Still, these drug usecrime relationships are not deterministic, nor do they look the same for all women, just as
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the process of recovery or desistance is highly individualized. Women’s pathway to
recovery may or may not include abstinence (from all or some substances), engagement
with self-help groups, or formal treatment services (including use of medications), and
the matrix of strategies that is helpful for one individual may not translate to others
(White & Kurtz, 2006). Recovery can be facilitated through the growth of women’s
physical, social, and human resources (i.e., recovery capital), and this supportive
development of women’s recovery capital can have long-term, sustainable, positive
outcomes (Cleveland et al., 2021). However, acknowledging that problematic drug use
can have dire chronic physical and mental health consequences, including death, there is
a critical need for research, practice, and advocacy to focus specifically on the avoidance
or reduction of harm associated with drug use (Marlatt, 1996). Simply stated, “Dead
people don’t recover” (Nguyen, 2020).

1.3

Dissertation research
Women’s unique pathways and transitions into and out of drug use/criminal legal

system (CLS) involvement are crucial to consider from a prevention, intervention, or
treatment perspective. Research has consistently demonstrated that women are distinct
from men in initiation, patterns, and trajectories of drug use, with important differences
on biological, environmental, and sociocultural levels (Becker et al., 2017; Kuhn, 2015;
McHugh et al., 2018). Women’s biological sex is foundational to the ways in which
women experience substances and pattern their use, yet gender is perhaps even more
deeply embedded in substance-using behaviors, given that heteronormative feminine
gender roles script women’s behaviors and interactions with others. A woman’s social
experience as a woman – her gender – shapes her trajectories of relationships with
5

family, peers, and significant others (including experiences of abuse or neglect);
education, housing, and employment; and interactions with institutions (e.g., healthcare);
all of which relate to patterns of CLS involvement and drug use. However, women’s
unique experiences – to the extent that they are considered at all, given women’s
persistent underrepresentation in SUD research (Gunn et al., 2022) – are rarely
considered using a gendered, sociological lens. Thus, this dissertation represents a
unique synthesis of sociological, criminological, public health, and harm reduction
perspectives to address key knowledge gaps related to women’s unique trajectories of
drug use and CLS involvement.
Specifically, this dissertation will employ a three-paper format to examine three
transitional events, with event representing a timepoint that may create an escalation of
risk for disease transmission and mortality, or, alternatively, that may be amenable to
intervention. The three papers will discuss: 1) the social and environmental context of
women’s initiation to injection drug use (IDU); 2) unique correlates of women’s
experiences with overdose and overdose reversal; and 3) reentry to the community postincarceration for women who have received corrections-based substance use treatment
services. Each paper is briefly described below, including research questions,
hypotheses, and data sources.
1.3.1

Paper #1 (Chapter 2): “Rural Appalachian women’s injection initiations and
correlates of providing injection initiation assistance”
Although drug use generally can produce risks to women’s well-being, such risks

exist along a continuum, with certain drug-using behaviors presenting a greater degree of
risk for negative outcomes than others. Injection drug use (IDU), particularly intravenous
IDU, is often cited as a particularly risky behavior in terms of the potential for
6

transmission of HIV or hepatitis C (HCV), development of skin or heart infections, and
heightened risk of overdose (CDC, 2020). Furthermore, compared to people who use
drugs by other routes, people who inject drugs are more likely to meet SUD diagnostic
criteria, perceive a need for treatment, and report co-occurring physical and
psychological problems (Novak & Kral, 2011), and women who inject drugs have a
greater risk of mortality and HIV infection compared to men (Mathers et al., 2013;
Roberts et al., 2010). Finally, despite increasing problems associated with drug use in
rural Appalachian areas (Moody et al., 2017; NACO/ARC, 2019), women’s experiences
with IDU transitions in this unique regional context remain understudied. Per the
relational model of women’s psychological development (Covington, 1998; Covington &
Surrey, 1997; Finkelstein, 1996; Jordan et al., 1991), women’s relationships with others
may be a unique vector of risk or source of support. However, the relational contexts of
women’s transitions to IDU in Appalachian areas remain understudied, and even less is
known about Appalachian women’s provision of IDU initiation assistance (IIA) to others.
Acknowledging the risks inherent in IDU and the importance of preventing such
transitions from occurring, the first paper will use cross-sectional data from the Women’s
Intervention to Stop HIV/HCV (WISH), a study conducted with women recruited from
three rural Appalachian jails and screened for high-risk substance use and sexual risk
behaviors. This paper will focus on two specific research questions, namely:
RQ1: What are the social and environmental contexts of IDU initiation
experiences retrospectively reported by a sample of high-risk, incarcerated
women from one rural Appalachian region?
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RQ2: Of women’s IDU initiation experiences, substance use patterns, and
relationships with others, what factors are associated with women reporting
having provided IIA to others?
It is hypothesized that women will be more likely to have provided IIA if they 1)
received IIA at their own initiation to IDU; 2) exhibit patterns of early initiation, faster
trajectories to problematic use, and greater current drug use severity; and 3) report fewer
prosocial relationships and more relationships with peers who use drugs.
1.3.2

Paper #2 (Chapter 3): “Experiences with overdose among women prior to
entering corrections-based treatment for substance use disorder”
Although fatal overdoses have become increasingly preventable as the opioid

overdose reversal drug naloxone has become more widely accessible, the age-adjusted
rate of drug overdose deaths has more than tripled from 1999 to 2018, indicating a need
for continued research and resource allocation (Hedegaard et al., 2020). The need for
women-centered overdose research is particularly critical in CLS-involved populations,
which are at heightened risk of overdose, especially transitions to community postincarceration (Ranapurwala et al., 2018). Although harm reduction frameworks typically
target individual-level risk factors (Marlatt, 1996; SFAF, 2020) and women themselves
often cite internal/personal attributions for overdose experiences (Ataiants et al., 2020a;
Lamonica et al., 2021), this individual-level focus should not overshadow factors at the
environmental or structural level. Additionally, there is a dearth of research examining
overdose (experiencing and/or witnessing) as a traumatic event, particularly to explore
factors that may mitigate symptoms of post-traumatic stress disorder (PTSD).
To that end, this second paper will examine women’s self-reported experiences
with nonfatal overdose, as well as witnessing overdose and naloxone sourcing knowledge
8

(i.e., knowing where to obtain naloxone), among a sample of women entering
corrections-based substance use treatment programming. Secondary data were obtained
from the Criminal Justice Kentucky Treatment Outcome Study (CJKTOS), a longitudinal
state-funded evaluation of corrections-based substance use treatment in Kentucky.
Specifically, the paper includes baseline CJKTOS data collected from women at
treatment entry, describing their experiences prior to incarceration. Using an
intersectional risk environment framework (Collins et al., 2019), this paper examines the
following research questions:
RQ3: What are the unique correlates of women’s experiences with nonfatal
overdose, witnessing overdose, and naloxone sourcing knowledge, across all three
levels of the intersectional risk environment (individual, structural, and
intersectional)?
RQ4: Are interactions between women’s experiences of nonfatal overdose,
witnessing overdose, and naloxone sourcing knowledge associated with different
likelihoods of reporting symptoms consistent with PTSD?
It is hypothesized that factors across all three levels of the intersectional risk
environment will be significantly associated with the overdose-related variables of
interest. Additionally, it is hypothesized that likelihood of PTSD will be greater among
women who have experienced or witnessed an overdose, but that naloxone sourcing
knowledge will significantly moderate one or both of these relationships, associated with
lower odds of meeting PTSD criteria.
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1.3.3

Paper #3 (Chapter 4): “Understanding women’s drug use following correctionsbased substance use disorder treatment and community release: A mixed methods
social-ecological analysis”
Women with a history of substance use who enter the CLS often do so with

accumulated disadvantages to their health and well-being, including IDU and overdose
experiences, yet women’s transitions from jail or prison to the community present
additional and unique challenges. Post-release, many formerly incarcerated women face
difficulties with securing housing, accessing public assistance, and finding employment,
whether due to limited resources, stigma, or having a criminal record (Flowers, 2010; Li,
2018). Furthermore, many women must navigate repairing damaged relationships,
coping with loss of child custody and the role of “mother,” and establishing membership
within supportive communities (Allen et al., 2010; Koski & Costanza, 2015; Leverentz,
2014). These factors align with discourse on building CLS-involved women’s recovery
capital – promoting resources that will support women’s growth and positive change
while reducing problems associated with drug use (Cleveland et al., 2021) – and for
women returning to the community, maintaining abstinence may be one important marker
of success. These factors can be usefully organized using social ecological frameworks
(Golden & Earp, 2012; McLeroy et al., 1988) to examine elements across multiple
hierarchical levels of influence (individual, interpersonal, institutional, and community).
However, there is a dearth of reentry research which has purposefully included variables
or performed targeted analysis across multiple social ecological levels to examine
outcomes related to drug use. Additionally, mixed methods approaches are rarely utilized
to compare and contextualize quantitative outcomes with qualitative data, to describe
women’s recovery processes in their own words.
10

To address these gaps, the third and final paper will examine factors associated
with abstinence from illicit drug use among women reentering the community after
receiving corrections-based substance use treatment. Data were obtained from the
follow-up component of the CJKTOS study, in which a stratified random sample of
program graduates complete phone-based interviews with research staff at 12 months
post-release to assess community outcomes. This paper will address the following
specific research questions:
RQ5: Which factors, at which social ecological levels, are quantitatively
associated with women self-reporting any illicit drug use after release from
incarceration?
RQ6: How do women qualitatively describe the barriers and facilitating factors
for abstinence in the community?
RQ7: Are factors associated with abstinence vs. a return to drug use identified
through quantitative and qualitative analyses similar or different?
It is hypothesized that factors at each social ecological level will be associated
with women’s likelihood abstinence after release, with many findings consistent with
prior research (e.g., employment, social supports, health service utilization; Andersson et
al., 2019; Flynn et al., 2004; Staton et al., 2019). It is also hypothesized that analysis of
women’s qualitative responses will reflect complex internal and relational attributions for
returning to drug use. Although there are likely to be similarities across quantitative and
qualitative results, it is hypothesized that each type of analysis will highlight unique
insights into barriers and facilitating factors for abstinence post-release.
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1.3.4

Conclusions (Chapter 5)
This final chapter concludes the dissertation, summarizing and synthesizing the

findings from the previous three chapters, examining three critical transitional events or
periods in women’s trajectories in drug use and CLS involvement. These events may
increase women’s risk for disease transmission and mortality or may present
opportunities for intervention. Thus, this final chapter provides an overview of
implications for prevention, intervention, and treatment of women’s substance use and
related issues, including recovery support and harm reduction services. The chapter also
focuses on the need for continued use of multilevel theoretical models in substance
misuse research and the value of including women’s unique qualitative perspectives
alongside quantitative analytic approaches. Directions for future research are discussed.
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CHAPTER 2. RURAL APPALACHIAN WOMEN’S INJECTION INITIATIONS AND CORRELATES
OF PROVIDING INJECTION INITIATION ASSISTANCE (PAPER 1)
2.1

Introduction
With the recent growth in opioid drug use in rural areas (Moody et al., 2017;

NACO/ARC, 2019), growing attention has been given to injection drug use (IDU), an
increasingly common phenomenon (Zibbell et al., 2015) associated with heightened risk
of infectious disease transmission or fatal overdose (Staton et al., 2018a). Harm
reduction-focused research has centered on understanding the IDU initiation event to
identify potential avenues of intervention, to prevent individuals from transitioning to this
riskier route of drug administration (as opposed to smoking or snorting; Werb et al.,
2018). While previous studies have demonstrated that women’s experiences of injection
initiation are unique from men’s (Bryant & Treloar, 2007; Simmons et al., 2012), less
research has focused on women in rural areas (Young et al., 2014), and especially
women’s initiation of others to IDU. Thus, the purpose of the present paper is two-fold:
1) to examine the context of injection initiation in a sample of high-risk rural
Appalachian women, and 2) to explore factors associated with women’s likelihood of
having initiated others to IDU, including women’s own initiation experiences, substance
use profiles, and relationships with others.
2.1.1

IDU Initiation in Rural Appalachian Contexts
Most injection initiation research has focused on urban contexts, though there is

reason to believe that initiation to IDU in rural environments may be distinct, particularly
in the unique geocultural context of rural Appalachia. Broadly, patterns of substance use
tend to vary by rural and urban context (Gfroerer et al., 2007) on the basis of availability

(e.g., high prescription rates for opioid analgesics in rural and suburban areas leading to
greater risk of diversion; Cicero et al., 2007) and cultural norms (e.g., initiation of
substance use as a rite of passage to adulthood; Hedges, 2012). Many rural Appalachian
areas have recently experienced structural stressors, such as industry and job sector shifts,
that may increase drug use as individuals seek to alleviate boredom from unemployment,
capitalize on burgeoning illicit economies, or treat chronic pain associated with manual
labor (Hansen et al., 2021; Keyes et al., 2014; Roberson et al., 2020). Furthermore,
living in a geographically dispersed Appalachian region may limit access to health and
substance use treatment services, as well as potential exposure to harm reduction
education or resources (Cummings et al., 2014; Edmond et al., 2015; Letourneau, 2021;
Moody et al., 2017; Young et al., 2015).
Culturally, communities in these areas tend to have strong and close-knit family
and kinship networks, which may serve as a source of support and resilience, or of
transmission of drug-using behavioral norms (Keyes et al., 2014). These networks can be
made more dense and exclusive by a skepticism or distrust of outsiders, adding to a
culture of “cooperative independence” (valuing both self-reliance and interdependence
with family and kin; Russ, 2010, p. 2). However, these characteristics also reflect a
history of marginalization that has contributed to myriad health and economic disparities
(Behringer & Friedell, 2006; Hartley, 2004). Moreover, the intersectional
marginalization of racial and ethnic minority Appalachian populations is often
overlooked in substance use research, given that the preponderance of studies in this
region have focused on majority white samples (i.e., 90% or greater; Schalkoff et al.,
2020). Although this is not inconsistent with regional demographics (at least 87% white
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in nonmetro Appalachian counties; Pollard & Jacobsen, 2022), it perpetuates the
dominant narrative of addiction as a white issue, alienating Black Appalachians from
treatment services and recovery support spaces (Good, 2021).
Finally, Appalachian women’s experiences with drug use must be contextualized
within gendered, heteronormative cultural expectations. Appalachian women may be
held against standards of fidelity to partners (even in domestic violence situations), moral
obligations to kin and community, and exclusion from employment opportunities, all of
which can enmesh them in drug-using relationships or social networks and exacerbate
gendered experiences of stigma (Buer et al., 2016). Early and Grundetjern (2022)
described how “compulsory” cisgender heterosexuality within rural drug markets scripts
women’s interactions, including hypersexualization and masculinized violence.
Although little IDU initiation research has focused in this area, it seems likely that these
unique aspects of life in rural Appalachia may shape an individuals’ propensity to
transition to IDU.
2.1.2

Women’s Gendered Experiences of Injection Initiation
In addition to unique facets of the rural environment, research has also

demonstrated that women’s injection initiation experiences are unique from men’s
(Meyers et al., 2020). Firstly, women are more likely to initiate IDU in the context of
romantic partnerships, contributing to the fact that women are less likely to have control
over the injection circumstances (e.g., sourcing of equipment or drugs; Simmons et al.,
2012). Women may also experience a faster transition from initiation to regular injection
(Bryant & Treloar, 2007), aligning with the “telescoping” of women’s addiction, a
phenomenon in which women initiating substance use may be more likely to experience
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symptoms of addiction after a shorter period of time than men and more rapidly seek
treatment (Haseltine, 2000; Kuhn, 2015). Finally, one study found that rural women
were significantly more likely than men to have been initiated by a romantic partner, to
have received the drugs as a gift, to have used an unclean syringe, and to have the
injection equipment provided by their partner (Young et al., 2014). These differences
emphasize the social nature of IDU transitions, particularly for women, and the need to
consider risk created by gendered power dynamics – especially those in rural,
Appalachian areas – that disempower women and place them at heightened risk of
disease transmission, overdose, injury, or victimization.
The emphasis in several studies highlighting women’s likelihood of initiation in
context of intimate partnerships also aligns with a social discourse of women as more
vulnerable than men and more susceptible to influence (including chemically; Campbell,
2000). Although there is qualitative evidence to suggest that women who are initiated by
partners may perceive an emotional benefit from transitioning to IDU, demonstrating
commitment and building closeness in shared experiences (Simmons et al., 2012), a large
number of women initiating IDU do so outside of romantic/sexual contexts. One urban
study found that women were most likely to report having been initiated by others who
were female (65%, usually friends or relatives) rather than male (Doherty et al., 2000).
Another found that less than half (47.3%) had a partner who also injected at the time of
their initiation, and only 32.4% of women were first injected by their partners (with the
remainder injected by a friend, themselves, or another acquaintance; Bryant & Treloar,
2007). Although romantic and sexual relationships may play an important role in
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influencing women’s transitions to IDU, the social context of injection initiation is often
more complex and nuanced and it is unclear how this plays out in a rural context.
2.1.3

Women and Initiating Others to IDU
Despite a sizeable body of research examining individuals’ experiences of being

initiated into IDU, less work has been done to examine this process from the perspective
of the individual providing injection initiation assistance (IIA). This perspective is
critical from an intervention standpoint, as the majority of IDU initiations occur under the
guidance or supervision of a more experienced individual: indeed, a recent systematic
review determined that between 53%-95% of injection initiations occur with one
individual injecting another, while 74%-100% occur under the help, guidance, or other
assistance of another person (Gicquelais et al., 2020). However, the process of assisting
in another’s IDU initiation may be a stigmatizing and sensitive topic. Qualitative
research suggests that individuals providing IIA may be asked repeatedly or pressured by
others to assist with IDU initiation and may be motivated to do so out of a desire to
ensure the initiate’s safety (e.g., with proper injection procedures and sterile equipment;
Guise et al., 2018). However, those providing assistance may also experience shame,
guilt, or regret at having facilitated a transition to a riskier form of use (Wenger et al.,
2016). Less than 10% of syringe exchange clients at one rural program indicated that
they would be likely to initiate someone to IDU in the future (Allen et al., 2021).
Although women may be less likely than men to be asked to initiate someone else
(Bluthenthal et al., 2015) or to report having initiated others previously (Gicquelais et al.,
2020), research has also suggested that this likelihood may vary by geography or place
(Meyers et al., 2018). In a pooled study of community samples of people who inject
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drugs, Meyers and colleagues (2018) found that gender was associated with significant
differences in likelihood of having provided IIA in Tijuana, Mexico, but not in San
Diego, USA or Vancouver, Canada, further emphasizing the importance of considering
the sociocultural context of injection initiation. Additionally, given that the IDU
initiation process is guided extensively by social norms, expectations, and relationships
(Guise et al., 2017), it stands to reason that rural Appalachian women’s choices to
provide IIA to others, framed by gendered experiences of drug use and socialization,
would rely on a calculus distinct from men’s.
2.1.4

Theoretical Framework: Extending the Relational Model
Many gendered theories of substance use have been grounded in the Relational

Model (Covington, 1998; Covington & Surrey, 1997; Finkelstein, 1996; Jordan et al.,
1991), which proposes that the significance of relationships to women makes social
networks a unique vector of risk and/or source of support. This relational model was
primarily developed in context of criminological research as a means to frame women’s
motivations for engaging in, or desisting from, criminal behavior. For example, women’s
relational “goals” may contribute to desistance, in that they increase women’s attachment
and commitment to others. More so than men, women may be motivated to avoid the
disconnection of relationships with children, partners, or other family that would result
from arrest or incarceration, supporting a generally lower rate of crime – the “loss of
positive stimuli” originally posited under General Strain Theory as motivation against
criminal behavior (Agnew, 1992). Findings from qualitative research confirm that
women’s positive relationships are an important source of emotional, social, and material
support during the community reentry process, and that rebuilding damaged relationships
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– particularly with children – may be an important part of women’s desistence narratives
(Leverentz, 2014). However, women’s relational focus may also contribute to
commission of illegal acts; women may commit crimes in context of intimate
partnerships, or be motivated by family responsibilities when engaging in financial
crimes (such as embezzlement, theft, or shoplifting; Chesney-Lind & Pasko, 2012).
Emphasis on the relational model has furthered important developments in
gender-responsive substance use treatment programs, to address women’s unique and
gendered needs, including trauma, mental health, self-sufficiency (e.g., relative to
education and employment), and – notably – relationships (with significant others,
children, family, and peers; Caputo, 2014; Chesney-Lind & Pasko, 2021; Morash, 2010).
However, relational frameworks may portray social forces as overly influential in
women’s lives, thus failing to fully acknowledge women’s agency and resistance against
these forces of social control. Social influences may structure, shape, and limit women’s
behavior, but women, as social actors, may also exercise agency in opposition or
resistance to these constraints.
Extending the relational model to women’s experiences with IDU initiation, many
women initiate IDU in the context of relationships with partners who also engage in IDU
(Bryant & Treloar, 2007). These women may frame their desire to transition as an
expression of closeness and commitment to their partner (Simmons et al., 2012), aligning
with research indicating that women who inject drugs are more likely to be in
relationships with men who also inject drugs (Staton et al., 2018a). Furthermore, women
in relationships with men who inject drugs are more likely to report sharing syringes or
other injection equipment, particularly if they also report less power in the relationship
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(Staton et al., 2017). These patterns of initiation and use align with the relational model’s
emphasis on social connections or partnerships as significant for women’s engagement
and desistance in deviant behaviors. Additionally, given the close-knit family and
kinship networks and heteronormative, gendered expectations of women in rural
Appalachian areas, relational influences contributing to likelihood of IDU initiation may
be even more salient.
However, countering narratives about women being “led astray” into drug use by
men, other women may instead describe the circumstances of drug use initiations or
transitions in terms of their own willingness and volition, even as a form of resistance
(Anderson, 2008; Ettorre, 2007; Hunt & Antin, 2019; Taylor 1993). Similarly, the
process of initiating others to IDU and providing IIA may be an expression of agency and
volition as women take on the empowered role of teacher or facilitator, but the process is
also often grounded in altruistic relational motivations (e.g., preventing immediate harms
to the initiate; Barnes et al., 2018). Although Appalachian women may be constrained by
stereotyped expectations of femininity, cultural values also foster women’s resilience and
strength (Helton & Keller, 2010); thus, within this context, providing IIA may be an
expression of independence. To summarize, the influence of relationships for many
substance-using women is a central one, but discourse on the power of women’s
relationships should be balanced by considerations of their agency.
2.1.5

Present Study
This paper focuses on the social aspects of injection initiation, specifically: 1)

describing the social environment and circumstances of rural Appalachian women’s
retrospectively self-reported initiation to IDU (including other individuals present or
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assisting with the first injection), and 2) examining differences between women who
report having ever provided IIA and those who have not, with a focus on women’s own
injection initiation experiences, recent drug use profiles, and relationships with others.
Very limited research has focused on the experience of rural individuals initiating others
to IDU (White et al., 2020), and none with a gender-specific lens. Therefore, this paper
makes a unique contribution by exploring how rural Appalachian women’s own
experiences with IDU initiation, substance use patterns, and relationships are associated
with differences in their likelihood of initiating others, which broadens the knowledge
base of relational contexts of rural IDU transitions/IIA and has important implications for
harm reduction-based interventions in rural areas.

2.2
2.2.1

Methods
Participants and Procedures
Data for this study were collected as part of a larger project (NIH/NIDA, R01-

DA033866) to reduce HIV/Hepatitis C (HCV) risk behaviors among incarcerated rural
women (see Staton et al., 2018b). Participants were randomly selected for recruitment
from three rural jails in Appalachian Kentucky (N=900) and screened for high-risk sexual
behavior and at least moderate risk for illicit drug abuse (as measured by a score of 4+ for
any drug on the NIDA-modified Alcohol, Smoking, and Substance Involvement
Screening Test; NM-ASSIST, NIDA, 2009). Of the 900 who were selected, 248 did not
meet study eligibility criteria, 101 refused to participate, 111 were released between
selection and screening, and 40 between screening and baseline completion. Eligible
women who were willing to participate and not released early (N=400) were interviewed
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by trained female research assistants in the jail between December 2012 – August 2015
and compensated $25 for their time. All data collection procedures were protected under
a federal Certificate of Confidentiality and approved by the University IRB. For the
present study, only women who reported ever injecting any drug (N=302) were included
in the final sample.
2.2.2

Measures
All participants reported age in years. Participants were also provided with a

series of race/ethnicity categories and asked to select all that applied (Caucasian/White;
African American/Black; Asian; Hispanic, Latino or Chicano; Native American; Pacific
Islander; or Other).
2.2.2.1 IDU Initiation
Women were asked to retrospectively self-report on several aspects of the first
time when they injected drugs.
2.2.2.1.1 SOCIAL ENVIRONMENT.
Women were asked whether they were alone for their first injection (=0) or with a
significant other (=1), family member (=2), or friend or acquaintance (=3); if they had
sex with anyone before or after their first injection (=1) or not (=0); and who injected the
participant the first time, whether a significant other (=1), family member (=2), or friend
or acquaintance (=3); variable was coded as 0 if the participant injected themselves. If
the participant received injection assistance the first time, they were also asked the age in
years of the person assisting, and whether that person was high on drugs or alcohol at the
time (=1) vs. sober or in withdrawal (=0).
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2.2.2.1.2 CIRCUMSTANCES OF IDU INITIATION.
Women were also asked to recall if they themselves were high on drugs or alcohol
at the time of their first injection (=1) vs. sober or in withdrawal (=0). Participants were
also asked whether they first injected an opiate or sedative drug (=0) or a stimulant (=1).
Opiate/sedative drugs reported were primarily prescription opiates (97.0%); stimulants
reported were mostly methamphetamine (51.5%) or cocaine (47.5%). Women also
reported whether the syringe used for their first injection was sterile/unused (=1) or
previously used/of unknown sterility (=0). Finally, women were asked whether they
procured the drugs for their first injection themselves and/or with their own money (=0)
or received them as a gift (=1), and whether the first injection occurred at a location
where the participant was living (=0) vs. some other location (=1).
2.2.2.2 Drug Use Patterns
Women responded to a series of questions and validated measures to assess their
history and patterns of illicit drug use.
2.2.2.2.1

INITIATION TIMING

Participants were asked to report the ages at which they first used any illicit drug
and first injected any drug. Age of first illicit drug use was then subtracted from age of
first injection drug use to calculate length of time in years between first drug use and first
injection. Finally, participants were asked how much time passed between the first time
they injected drugs and when they became a regular injector, selecting from ordinal
categories that were recoded as less than one month=1, more than one month=2, with
women who never regularly injected drugs as the reference group (coded as 0).
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2.2.2.2.2 DRUG USE SEVERITY PROFILE
Women were asked if they had ever experienced an overdose, seen anyone else
overdose, whether or not they had ever injected a list of specific drugs in their lifetime
(options presented in Table 2.2), and if they had injected drugs in the year prior to
incarceration (PTI; all coded as 0=no, 1=yes). Finally, participants responded to the
Substance Problem Scale (SPS) of the Global Appraisal of Individual Needs (GAIN;
Dennis et al., 2008), a 16-item validated measure of substance use problem severity, with
higher scores indicating greater severity of psychological, physiological, and social issues
associated with substance use (ɑ = 0.92). The SPS includes three subscales: the
Substance Issues Index (5 items; ɑ = 0.64), Substance Abuse Index (4 items; ɑ = 0.85),
and Substance Dependence Index (7 items; ɑ = 0.92), and participants were asked to
respond in terms of their use during the 12 months PTI.
2.2.2.3 Relationships
Participants were also asked to describe their relationships with partners, peers,
and family using the following measures.
2.2.2.3.1

PARTNER RELATIONSHIPS

Women self-reported their sexual orientation (recoded as heterosexual=1, other
sexual orientations=0) and marital status (recoded as currently married, remarried, or
living as married=1, all other marital statuses=0). Participants also reported if their last
main and casual male sexual partners had previously injected drugs and whether in their
lifetime they had ever engaged in transactional sex, defined as sex with a partner for
money, drugs, food, shelter, or transportation (yes=1, no=0 for all three variables).
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2.2.2.3.2

PEER RELATIONSHIPS

For each illicit drug, participants were asked how many people they had used or
shared that drug with during the six months PTI; the maximum number of people was
calculated for each participant across all substances reported. This metric was also
categorized as participants who reported no use during that timeframe (n=3) or only used
alone (=0), those who used with up to one or two people (=1), or those who used with up
to three or more people (=2).
Women also completed the Peer Criminality subscale of the Texas Christian
University Family and Friends Assessment (TCU FAFR; Joe et al., 2004), a validated
six-item scale measuring participants’ perceptions of their friends’ criminal behaviors in
the six months PTI (e.g., “how often did they [friends] use illegal drugs”) and higher
scores (range 10-50) indicating greater perceived criminality among peers (ɑ = 0.84).
Women who did not report contact with friends in the six months PTI did not complete
the scale; thus, scores were also categorized as no contact with friends (=0), low peer
criminality (scores 10-29, coded as 1), and high peer criminality (scores 30-50, coded as
2). Lastly, participants were asked if they had ever attended a peer recovery support
meeting (e.g., AA or NA; 0=no, 1=yes).
2.2.2.3.3

FAMILY AND CHILD RELATIONSHIPS.

Women reported the number of people in their family household. Women also
indicated whether they believed they were “doing well” with their family during the 12
months PTI, and whether or not they had used drugs or alcohol with family members
during the six months PTI (0=no, 1=yes). To describe relationships with parents,
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participants also completed the Family Relationships subscale of the TCU FAFR (Joe et
al., 2004), a validated seven-item scale measuring perceived conflict and warmth in
family relationships, with higher scores (range 10-50) indicating better-quality
relationships (ɑ = 0.83). The scale was modified slightly to refer only to participants’
parents or parental figures such as grandparents (e.g., “tell me how often you helped each
other with problems,” “tell me how often you got blamed or fussed at about things you
did or did not do [reverse coded]”) and is thus hereafter referred to as the Parental
Relationships Scale. Lastly, participants were asked if they had any children (0=no,
1=yes), how many children they had, and whether they had ever been involved with child
protective services (CPS) in their lifetime (0=no, 1=yes).
2.2.2.4 IDU Initiation of Others
Finally, participants were asked whether they had ever initiated or introduced
anyone to injecting drugs (0=no, 1=yes).
2.2.3

Analytic Plan
Descriptive statistics were calculated for all variables, including means, standard

deviations, and proportions. A series of chi-square and t-tests were calculated to compare
women who have initiated others to IDU to those who have not. For chi-square tests with
significant results and more than four cells, differences were explored using post hoc tests
of adjusted residuals (values greater than 2.0; MacDonald & Gardner, 2000). Finally,
variables for which significant bivariate differences existed were entered into a
multivariable logistic regression model, with a dependent variable of having ever initiated
someone else to IDU. To address potential multicollinearity issues, Pearson’s r was
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calculated for all variables to be included in the model. Age of first injection was highly
correlated with both current age (r=0.61) and years between first drug use and first
injection (r=0.79). Thus, age of first injection was excluded from the final model. All
other correlation values were below r=0.50. All analyses were conducted using Stata 15.

2.3
2.3.1

Results
Women’s IDU Initiation Circumstances
On average, participants were 31.6 years old and 99.3% White. As shown in

Table 2.1, few participants (9.9%) were alone at the time of their first injection; more
commonly, participants reported initiating IDU in the presence of friends/acquaintances
(51.3%), significant others (29.1%), or family members (9.6%). About a quarter (28.9%)
of women had sex with someone before or after their initiation event. Most women
(86.1%) received injection assistance from another individual while initiating; of those
who received assistance, two thirds (67.7%) were assisted by someone who was older
than them, and 86.5% were assisted by someone who was intoxicated on drugs or alcohol
at the time. Fewer participants were themselves intoxicated on drugs or alcohol at the
time of IDU initiation (54.6%). Most participants initiated by injecting an opiate or
sedative drug (67.2%) and used a sterile or new syringe (76.5%). Finally, 44.7% of
women were given the drugs used for IDU initiation as a gift, and about two-thirds
(65.6%) initiated in a place where they were living at the time.
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2.3.2

Bivariate Comparisons of Women Who Ever Initiated Another Person to IDU and
Those Who Have Not
Women who ever initiated another person to IDU (40.1%) were significantly

younger than those who had not (59.9%; p = .036). Further bivariate differences are
discussed below.
2.3.2.1 Injection Initiation Circumstances
Compared to women who had never provided IIA, women who ever initiated
another person were more likely to have been themselves initiated by someone who was
relatively older than themselves at the time (p = .019).
2.3.2.2 Drug Use Patterns
As displayed in Table 2.2, women who had ever provided IIA reported initiating
drug use at a younger age (p = .009), and IDU at a younger age (p < .001), compared to
those who had not. They also reported fewer years between initiation of drug use and
when they began to inject (p < .001). Adjusted residuals indicated that, compared to
expected proportions, women who had never initiated someone else to IDU were more
likely to report having never regularly injected drugs; those who reported providing IIA
were more likely to have transitioned from initiation to regular injection in less than one
month’s time (p < .001).
Compared to women who never provided IIA, women who ever initiated another
person were more likely to have experienced a nonfatal overdose (p = .004) and to have
ever injected prescription opiates (p < .001), heroin (p < .001), benzodiazepines (p <
.001), cocaine (p = .001), and prescription stimulants (p = .025). They also reported
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having injected a greater number of different drugs in their lifetime (p < .001) and were
more likely to report having injected drugs in the 12 months PTI (p < .001). Finally,
women who had ever assisted with initiating someone to IDU scored higher on the GAIN
Substance Problem Scale (p < .001), with significant differences on the indexes for
Substance Abuse (p < .001) and Dependence (p < .001).
2.3.2.3 Relationships
For partner or sexual relationships, women who ever initiated another person to
IDU were less likely to identify as heterosexual (p < .001) and more likely to report ever
having engaged in transactional sex (p < .001) than women who had never provided IIA
(results presented in Table 2.3). For peer or friend relationships, significant differences
were also noted in social drug use patterns during the six months PTI (p = .014); adjusted
residuals indicated that women who had ever provided IIA were less likely to report
having used illicit drugs only while alone (or not used), and more likely to report having
used with three or more other people, compared to expected proportions. These women
also scored significantly higher on the TCU Peer Criminality Scale (p = .003), even when
including women who said they had no contact with friends or peers in the six months
PTI (also p = .003), and were more likely to have ever attended a peer-led self-help group
(such as AA/NA; p = .019). Finally, for relationships with family and children, women
who had ever provided IIA were more likely to report having used drugs or alcohol with
family in the six months PTI (p = .002) and scored significantly lower on the TCU
Parental Relationships Scale (p = .015), indicating lower-quality relationships with
parents or parental figures (lower warmth, higher conflict).

29

2.3.3

Independent Correlates of Ever Having Initiated Another to IDU
Results from the logistic regression model are presented in Table 2.4, indicating

significant associations between having ever provided IIA and women’s own injection
initiation experiences, drug use patterns, and relationships. Many relationships observed
in bivariate analyses remained significant in the final multivariate model. Compared to
women who self-injected their first time, women who were injected by someone younger
(AOR = 0.30) or older (AOR = 0.36) than themselves were less likely to have later
initiated someone else. A faster transition from first illicit drug use to injection initiation
was also associated with higher odds of providing IIA (AOR = 0.91). Similarly,
compared to women who said they had never regularly injected drugs, those who started
injecting regularly, but more than a month after initiation, were over four times as likely
to also have ever provided IIA (AOR = 4.53). Those that transitioned from first IDU to
regular injection in less than a month were ten times more likely to report having
provided IIA (AOR = 10.00). Women who had injected a greater number of different
drugs in their lifetime were also more likely to have initiated someone to IDU (AOR =
1.23).
Identifying as heterosexual was associated with less than half the odds of
initiating another person to IDU (AOR = 0.42). Additionally, compared to women who
used drugs alone (or not at all) during the six months PTI, those who used drugs with
three or more other people were over twice as likely to have provided IIA in their lifetime
(AOR = 2.76). Compared to women who had no contact with peers or friends in the six
months PTI, women who scored in the upper half of the TCU Peer Criminality Scale
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were also more likely to have provided IIA (AOR = 4.54), as were women who had ever
attended a peer recovery support meeting (AOR = 2.31).

2.4

Discussion
Very limited research has focused on the experience of rural individuals initiating

others to IDU (White et al., 2020), and none with a gender-specific lens. Thus, this paper
has made a unique contribution by exploring factors associated with rural Appalachian
women’s likelihood of having ever initiated someone to IDU, including features of
women’s own injection initiation experiences, their patterns of substance use, and their
relationships with others.
The first aim of the study was to describe the social environment and
circumstances of rural Appalachian women’s retrospectively self-reported IDU
initiations. While just over a quarter of women were first injected by an intimate partner,
over half were injected by a friend, family member, or acquaintance, a notable finding
given the strong and close-knit social networks often found in Appalachian regions
(Keyes et al., 2014; Russ, 2010). Thus, despite research which emphasizes the fact that
women may be more likely than men to initiate IDU in context of intimate partnerships
(Young et al., 2014), the women in the present sample were still overall more likely to be
initiated by someone who was not a romantic or sexual partner – and more than one in
ten (13.9%) injected themselves for the first time. This rate of self-injection at IDU
initiation is relatively consistent with other studies with urban samples of women who
inject drugs, which have reported rates between 4.7% - 17.3% (Doherty et al., 2000;
Frajzyngier et al., 2007; Goldsamt et al., 2010; Roy et al., 2002). While the present
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sample is certainly unique, given that women were from a rural Appalachian region in
one state and were screened for high-risk drug use and sexual behaviors prior to study
enrollment, results suggest that the social contexts of women’s IDU initiation can be
diverse. However, given that almost all women described their IDU initiation as a social
event (i.e., not alone), future research should explore how the social environment of IDU
initiation may reflect women’s motivations to transition, to assess the influence of
partners, family members, or friends (per the Relational Model; Covington, 1998;
Covington & Surrey, 1997; Finkelstein, 1996; Jordan et al., 1991).
Regarding other features of women’s injection initiation experiences, it is a
noteworthy positive that three-fourths of women reported having used a syringe that was
sterile or new at their first injection, particularly given that syringe exchange programs
were not permitted to legally operate in Kentucky until 2015 (KY CHFS, 2022), the final
year of study enrollment. Of note, use of sterile injection equipment did not differ
significantly by year of arrest prior to study enrollment. However, the fact that over half
of participants were already intoxicated at the time of initiation may create a heightened
risk of overdose, particularly given that most participants initiated IDU using an opiate
drug. Additionally, the fact that 86.5% of individuals who assisted participants were
themselves intoxicated means that participants may have been at risk of developing
abscesses or other soft tissue infections if the individual assisting is less aware or
observant while injecting.
The second aim of the study was to examine factors associated with women’s
likelihood of having provided IIA to others. Overall, almost half of the women in the
present sample reported having ever assisted another person with IDU initiation. In a
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recent systematic review of studies describing lifetime provision of IIA, prevalence
estimates from 13 studies ranged from 13% - 69% (Gicquelais et al., 2020). The rate
observed in the present study, 40.1%, was only surpassed by two studies from the review,
one conducted in India (69.3%; Kermode et al., 2007) and one with adolescents and
young adults in Melbourne, Australia (47.3%; Crofts et al., 1996). The prevalence of
assistance provided by participants in the present study suggest that women who inject
drugs in rural Appalachian communities may be critical targets for peer-based harm
reduction interventions.
Although considerable heterogeneity was observed in the social and
environmental circumstances of women’s own IDU initiation, very few significant
differences were noted between women who later provided IIA and those who did not. In
the multivariable model, women who self-injected at their initiation event were more
likely to have initiated someone else, compared to women who were first injected by
another person (whether older or younger/same age to themselves). These women may
be more confident in their injection abilities and thus more willing to share their
knowledge with new initiates. Conversely, women who were initiated by another
individual may have conflicted or even negative emotions towards that person and may
not wish to play that role for others. However, no other significant differences were
found, suggesting that the circumstances of women’s own IDU initiation (e.g., setting,
other people present, sourcing of drugs and/or injection equipment) have little association
to their likelihood of providing IIA. Indeed, as a single event in women’s trajectories of
illicit drug use, this transition is personally significant for women in its escalation of risk
for disease transmission or overdose, but the social and environmental circumstances of
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women’s initiation to IDU may have little to no bearing on whether women assist others
in their initiation as well.
Despite few differences at the level of the IDU initiation event circumstances,
many significant differences were noted in women’s patterns of drug use. Specifically,
women who had initiated another person to IDU had more severe substance use. These
women scored higher on the GAIN Substance Problem Scale, were more likely to have
injected drugs recently (year before jail), to have ever overdosed, and to have injected a
greater number of different drugs in their lifetime. These patterns align with previous
research: for example, one study found a bidirectional relationship between providing IIA
and nonfatal overdose (Bowles et al., 2021), while another found that individuals who
provided IIA more frequently were more likely to also report more frequent IDU
(Navarro et al., 2019). Both studies included male and female participants yet did not
examine the observed relationships separately by sex, which may be an important area for
future research.
In the present study, women who had ever provided IIA also reported having
initiated illicit drug use and IDU at younger ages, to have transitioned more quickly from
first drug use to first injection, and were more likely to transition to regular injection drug
use, and more quickly after their first injection (<1 month). These women may have high
impulsivity and/or low inhibitory control that could contribute to faster use escalation
(Mitchell & Potenza, 2014) and to a greater likelihood of agreeing to assist others in IDU
initiation, despite the associated social stigma and moral ambiguity (Allen et al., 2021;
Guise et al., 2017; Guise et al., 2018; Wenger et al., 2016). However, these women may
also be more enmeshed in drug-using social networks, from a younger age, particularly
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networks of others who inject drugs; in social groups where IDU is an accepted route of
drug consumption, women’s own transitions may occur more rapidly, and there may be
less stigma perceived towards providing IIA (Gicquelais et al., 2020).
Considering women’s social environments, several differences were also noted at
the level of women’s relationships and their likelihood of having initiated others to IDU.
For example, women who had ever provided IIA were more likely to report having
recently used drugs with other people (vs. alone), particularly in larger groups (three or
more other people). These women were also more likely to have been in contact with
peers who rated high on the measure of peer criminality and to have recently used drugs
or alcohol with family members. The additional finding that women who had ever
initiated another to IDU were also more likely to have ever attended a peer recovery
support meeting raises the question whether women who engage in more social forms of
active drug use might also seek out more social pathways of recovery. However, it is
also possible that meeting attendance was mandated through criminal justice system
contact and reflects a history of incarceration and/or community supervision, which
previous research has shown to be associated with having provided IIA (Bryant &
Treloar, 2008).
These findings related to women’s social drug-using behaviors align with
previous research demonstrating associations between social normalization of IDU and
provision of IIA (Gicquelais et al., 2020). The principle of homophily, that “similarity
breeds connection,” may encourage women who inject drugs to form, join, or remain in
networks with others that engage in similar behaviors (McPherson et al., 2001). Since
networks of individuals who use drugs can be an important source of information and
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norms of drug use, women who self-report to providing IIA may be more likely to use
drugs with others because these may be social settings in which IDU-related knowledge
and expertise is a source of social capital (Kirst, 2009). Women may also be motivated to
provide IIA due to pressures from individuals in these networks and a well-meaning
desire to facilitate safe IDU procedures (Guise et al., 2018), consistent with the Relational
Model (e.g., Covington & Surrey, 1997). Conversely, women who use drugs alone (or
with few people) and choose not to associate with deviant peers may distrust other
individuals who use drugs, which may in turn reflect internalized stigma related to drug
use, particularly IDU (Ezell et al., 2022; Kirst, 2009), and negative beliefs about those
who provide IIA (Wenger et al., 2016). Although women who use and/or inject drugs
alone may not be effective targets for peer-based risk-reduction interventions, they are
nonetheless a critical population for future research given their high risk of experiencing
fatal overdose (Davidson et al., 2003; Siegler et al., 2014).
Finally, results from the present study indicated that women who had ever
provided IIA were also more likely to have engaged in transactional sex, consistent with
another recent study (Navarro et al., 2019). However, the finding that women who were
non-heterosexual were more likely to report providing IDU initiation assistance – even
when controlling for other significant factors – has not been documented in previous
research. A previous study with urban sexual minority women who inject drugs
documented a higher prevalence of negative health indicators, socioeconomic instability,
and fewer network resources compared to their heterosexual counterparts (German &
Latkin, 2015). This marginalization may contribute to sexual minority women’s
likelihood of providing IIA as a way of building social capital and dependent
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relationships within communities of individuals who use drugs; indeed, previous
qualitative research has highlighted the sometimes-transactional nature of providing IIA
in exchange for money or drugs (Wenger et al., 2016). Furthermore, the active and
empowered role of providing IIA can also be interpreted as a violation of gendered social
norms, which may be more salient to women who identify as heterosexual. Additional
research is needed to better understand this intersectionally marginalized population.
This study is subject to limitations. Participants’ retrospective accounts of IDU
initiation circumstances and timing may have been biased by recall, although the average
of first injection was only six years younger than women’s average current age (26.2 vs.
32.4). However, over half of women also reported being intoxicated at the time of IDU
initiation, which may further impact memory accuracy of the event. Data quality may
also be impacted by social desirability bias, given that participants were asked about
sensitive and highly stigmatized behaviors (e.g., providing IIA, use of non-sterile
syringes) in a face-to-face interview setting (Krumpal, 2013). However, it is hoped that
bias was minimized through interviewer training and recruitment of interviewers who
were female and local to the area, to facilitate trust and rapport with participants.
Findings may not be generalizable to other populations due to the unique nature
of the present sample (white, rural, Appalachian, incarcerated, and screened for substance
misuse and high-risk sexual behaviors). The use of cross-sectional data also precludes
causal inference: it is possible that providing IIA increases the likelihood of severe
patterns of drug use and high-risk relationships, or that these relationships and use
patterns create opportunities and motivations to provide assistance with IDU initiation.
Additionally, more contextual information is needed regarding women’s experiences
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initiating others to IDU, including how many “others” women have initiated, their
motivation for providing IIA, and the social, temporal, and physical context of these
initiation events. Studies using qualitative methods could shed more light on some of
these contextual issues. Future research should explore these specific details to identify
targets and tailor content for harm reduction and educational interventions.
Despite these limitations, this study makes a valuable contribution to the literature
by focusing on the injection initiation experiences of a unique and understudied
population which has historically lacked access to health and harm reduction resources.
Additionally, by focusing on factors associated with rural Appalachian women’s
likelihood of having provided IIA to others, this study highlights these women as
empowered and agentic. Findings expand the Relational Model’s position that women
may be motivated by relational commitments to others to engage in deviant behavior
(e.g., Covington & Surrey, 1997): although IDU transitions in the present study were
generally framed in a social context, women providing IIA may be positioned as
independent and knowledgeable resources, and thus also potentially valuable targets for
peer-based harm reduction interventions. Women who provide IIA in rural communities
of people who use drugs could facilitate satellite syringe exchange and/or be trained to
provide education related to naloxone overdose reversal, safe injection practices, abscess
wound care, and other related issues. Additionally, such women could also be offered
training (e.g., Motivational Interviewing) to empower them to discourage others from
transitioning to IDU from less-risky routes of drug use. Findings from the present study
suggest that women who exhibit trajectories of drug use characterized by faster
transitions and more severe patterns, identify as sexual minorities, and/or are more
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enmeshed in social networks of others who use drugs are more likely to have provided
IIA. Future studies should engage this community with additional qualitative research to
inform interventions that could reduce future IDU transitions or ensure that they happen
in a safe manner.
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Table 2.1 Bivariate comparisons of injection drug use (IDU) initiation circumstances
between women who ever initiated another person to IDU vs. not (N=302)
Never
Ever
initiated
initiated
Total
other
other
(N=302)
(n=181)
(n=121)
Demographics
Current age (range 19 – 57)*
32.4 (7.8) 30.5 (6.7) 31.6 (7.5)
Race/ethnicity
White
99.5%
99.2%
99.3%
Black/African-American
0.0%
0.8%
0.3%
Hispanic
0.5%
0.0%
0.3%
Social Environment of IDU Initiation
Who were you with the first time you
injected?
Alone
9.4%
10.7%
9.9%
Family member
7.7%
12.4%
9.6%
Significant other
29.3%
28.9%
29.1%
Friend or acquaintance
53.6%
47.9%
51.3%
Had sex with anyone before/after
25.0%
34.7%
28.9%
Who injected you?
Injected themselves
12.2%
16.5%
13.9%
Family member
7.2%
11.6%
8.9%
Significant other
27.6%
26.5%
27.2%
Friend or acquaintance
53.0%
45.5%
50.0%
Of participants who received injection
assistance the first time (n=260)…
Average age of person assisting injection
29.8 (8.2) 27.4 (7.4) 28.9 (8.0)
(range 14-60)*
Compared to participant, person assisting
62.3%
76.2%
67.7%
was older*
Person assisting was intoxicated on drugs
86.8%
86.1%
86.5%
or alcohol
Circumstances of IDU Initiation
Participant was intoxicated on drugs or
51.9%
58.7%
54.6%
alcohol
First injected opiate or sedative drug (vs.
65.2%
70.3%
67.2%
stimulant)
Syringe was sterile/new (vs. previously used
79.0%
72.7%
76.5%
or unknown)
Received drugs as a gift (vs. purchased and/or
42.5%
47.9%
44.7%
procured themselves)
First injection occurred in a place where
65.2%
66.1%
65.6%
participant lived (vs. other location)
*p≤.05
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Table 2.2 Bivariate comparisons of drug use patterns between women with history of
IDU who ever initiated another person to IDU vs. not (N=302)
Never
Ever
initiated
initiated
Total
other
other
(N=302)
(n=181)
(n=121)
Initiation Timing
Age of first drug use (range 8-37)**
16.3 (4.8) 14.9 (4.1) 15.7 (4.6)
Age of first injection (range 13-51)***
26.2 (7.4) 22.2 (5.9) 24.6 (7.1)
Years between first drug use and first injection
10.0 (7.4)
7.3 (5.6)
8.9 (6.9)
(range 0-37)***
Time between initiation and injecting
regularly***
Never regularly injected drugs
26.5%
3.3%
17.2%
Less than one month
40.9%
65.3%
50.7%
More than one month
32.6%
31.4%
32.1%
Drug Use Severity Profile
Ever overdosed**
33.2%
49.6%
39.7%
Ever witnessed someone overdose
51.9%
62.0%
56.0%
Ever injected…
Prescription opiates***
81.8%
98.4%
88.4%
Methamphetamine
63.0%
71.1%
66.2%
Cocaine***
45.3%
64.5%
53.0%
Heroin***
26.5%
57.0%
38.7%
Benzodiazepines***
22.7%
45.5%
31.8%
Prescription stimulants*
19.3%
30.6%
23.8%
Suboxone/Subutex
8.3%
12.4%
9.9%
Total number of different drugs ever injected
2.7 (1.5)
3.8 (1.6)
3.1 (1.6)
(range 1-7)***
Injected drugs in the past year PTI***
72.4%
90.1%
79.5%
GAIN Substance Problem Scale (SPS; range 012.8 (4.5) 14.4 (2.5) 13.4 (3.9)
16)***
Substance Issues Index (range 0-5)
3.8 (1.4)
3.9 (1.1)
3.9 (1.3)
Substance Abuse Index (range 0-4)***
3.1 (1.4)
3.7 (0.9)
3.4 (1.2)
Substance Dependence Index (range 0-7)***
5.9 (2.1)
6.7 (1.0)
6.2 (1.8)
*p≤.05, **p≤.01, ***p≤.001
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Table 2.3 Bivariate relational differences comparing women with history of IDU who
ever initiated another person to IDU vs. not (N=302)
Never
Ever
initiated
initiated
Total
other
other
(N=302)
(n=181)
(n=121)
Partner/Sexual Relationships
Heterosexual (vs. non-heterosexual)***
84.5%
65.3%
76.8%
Married, remarried, or living as married
33.2%
36.4%
34.4%
Last main sex partner ever injected drugs
57.5%
66.9%
61.3%
Last casual sex partner ever injected drugs
18.2%
25.6%
21.2%
Lifetime history of transactional sex***
44.8%
69.4%
54.6%
Peer Relationships
Max number of people participant used illicit
1.98 (2.6)
2.3 (2.5)
2.0 (2.6)
drugs with in 6 months PTI (range 0-24)
In 6 months PTI, did participant use drugs…*
No use/only alone
22.7%
12.4%
17.7%
With up to 1-2 other people
58.0%
56.2%
57.9%
With 3 or more other people
19.3%
31.4%
24.4%
TCU Peer Criminality Scale (range 10-50;
29.6 (8.2) 32.4 (7.0) 30.7 (7.8)
n=268)**
Trichotomized TCU Peer Criminality**
No contact w/ any friends in 6 months PTI
13.8%
7.4%
11.3%
Low peer criminality (10-29)
39.2%
25.6%
33.8%
High peer criminality (30-50)
47.0%
66.9%
55.0%
Ever attended peer recovery support meeting*
71.8%
83.5%
76.5%
Family and Children Relationships
Number of people in family household (range 0-8)
3.4 (1.6)
3.1 (1.5)
3.3 (1.5)
“Doing well with your family” in 12 months PTI
74.6%
66.9%
71.5%
Used drugs or alcohol with family in 6 months
42.0%
60.3%
49.3%
PTI**
TCU Parental Relationships Scale (range 10-50)*
34.6 (7.2) 32.3 (8.5) 33.7 (7.8)
Participant has any children
89.5%
82.6%
86.8%
Number of children (range 0-7)
2.2 (1.4)
2.2 (1.6)
2.2 (1.5)
Ever been involved with CPS
49.7%
51.2%
50.3%
*p≤.05, **p≤.01, ***p≤.001
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Table 2.4 Independent correlates of ever having initiated another to IDU (N = 302)
Current age
Comparative age of person who assisted with
IDU initiation (ref. group: self-injected first
time)
Younger or same age*
Older*
Age of first drug use
Years between first drug use and first injection**
Time between initiation and injecting regularly
(ref. group: never injected regularly)
Less than one month***
More than one month*
Ever overdosed
Total number of different drugs ever injected*
Injected drugs in the past year
GAIN SPS Total Score
Heterosexual*
Lifetime history of transactional sex
Max number of people used drugs with in 6
months PTI (ref. group: no use/only alone)
1-2 people
3 or more people*
TCU Peer Criminality Scale (ref. group: no
friends in 6 months PTI)
Low peer criminality
High peer criminality**
Ever attended peer recovery support meeting*
Used drugs/alcohol with family in 6 months PTI
TCU Parental Relationships Scale
Pseudo R2 = 0.29
*p≤.05, **p≤.01, ***p≤.001
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AOR
1.04

95% CI
[0.99, 1.09]

SE
0.03

p-value
0.167

0.30
0.36
0.93
0.91

[0.11, 0.83]
[0.14, 0.92]
[0.86, 1.01]
[0.85, 0.96]

0.16
0.17
0.04
0.03

0.020
0.033
0.076
0.002

10.00
4.53
1.59
1.23
1.66
1.02
0.42
1.58

[2.87, 34.87]
[1.26, 16.26]
[0.85, 3.00]
[1.00, 1.50]
[0.63, 4.17]
[0.92, 1.14]
[0.20, 0.89]
[0.83, 3.02]

6.37
2.95
0.51
0.13
0.78
0.06
0.16
0.52

<0.001
0.021
0.147
0.046
0.312
0.671
0.023
0.168

1.06
2.76

[0.44, 2.57]
[1.01, 7.52]

0.48
1.41

0.900
0.047

3.01
4.54
2.31
1.57
0.99

[0.99, 9.16]
[1.59, 12.98]
[1.10, 4.84]
[0.86, 2.86]
[0.95, 1.02]

1.71
2.43
0.87
0.48
0.02

0.053
0.005
0.027
0.144
0.513

CHAPTER 3. EXPERIENCES WITH OVERDOSE AMONG WOMEN PRIOR TO ENTERING
CORRECTIONS-BASED TREATMENT FOR SUBSTANCE USE DISORDER (PAPER 2)
3.1

Introduction
As drug overdose deaths have quadrupled over the past 20 years (CDC, 2021a),

strategies to reduce overdose fatalities (e.g., distribution of naloxone [Narcan®] or
fentanyl test strips) have become a critical focus of public health initiatives. Nonfatal
overdose experiences may also be an important opportunity to offer harm reduction
resources or linkages to treatment, including induction to medications to treat opioid use
disorder (MOUD). However, little research to date has focused on women’s experiences
with nonfatal overdose or overdose reversal, despite documented gender differences in
other areas of drug use and evidence that the overdose death rate among women is rising
more quickly than among men (McHugh et al., 2018). The need for women-centered
overdose research is particularly critical in criminal legal system (CLS)-involved
populations, which are at heightened risk of overdose, especially at the point of reentry to
the community post-incarceration (Ranapurwala et al., 2018). Thus, the present paper
explores experiences with nonfatal overdose, as well as witnessing overdose and
naloxone sourcing knowledge (i.e., knowing where to obtain naloxone), among a sample
of women entering corrections-based substance use treatment programming in one
southern state. Using an intersectional risk environment framework (Collins et al., 2019),
unique correlates of overdose experiences are examined at the individual level,
structural/environmental level, and the intersection of the two. Furthermore, this paper
investigates the unique associations between overdose experiences and women’s
symptoms of post-traumatic stress disorder (PTSD) to highlight overdose as a traumatic

event and to discuss future interventions to reduce overdose-related harms to women’s
physical and mental health.
3.1.1

Women’s Overdose Experiences
Although the number of opioid-involved overdose deaths remains higher among

men than women (NIDA, 2021), the rate of opioid-involved overdose deaths among
women is increasing at a staggering rate (Hedegaard et al., 2020; VanHouten et al.,
2019), particularly for some subtypes of opioid drugs (i.e., prescription opioids; Mazure
& Fiellin, 2018). Indeed, between 1999 and 2017, the rate of age-adjusted overdose
deaths involving an opioid rose 671% among women (from 1.4 to 9.4 per 100,000),
compared to a 474% increase among men (4.3 to 20.4; Kaiser Family Foundation, 2022).
Gender differentials in overdose mortality, which converge and diverge over time, reflect
shifting patterns of gendered social norms, risk aversion, and drug preferences (Ho,
2020), all of which have important implications for overdose prevention and intervention
efforts. Although research has suggested that risk factors for experiencing overdose are
generally similar for men and women, the presentation and prevalence of given risk
factors may exhibit key differences based on individuals’ gendered experiences of drug
use (Chang et al., 2019; Darke & Hall, 2003; Macmadu et al., 2021; Malta et al., 2019;
Ranapurwala et al., 2018).
Women who use drugs, by fact of their embeddedness in social networks of other
individuals who use drugs, are also likely to be present in the event of another person’s
overdose. Thus, women who are at highest risk of experiencing overdose are also likely
to be in a position to provide overdose reversal interventions to others. Indeed, lifetime
experiences of witnessing overdose among global samples of people who use drugs have
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been estimated at 50-96%, with a mean of 73.3% (Martins et al., 2015). Although an
urban community-based study found that men who use drugs were more likely to witness
a greater number of overdoses than their female counterparts (Bohnert et al., 2012), such
gender differences may vary depending on region, or within subsets of substance-using
communities. For example, in one study of CLS-involved men and women in diversion
addiction treatment, women were more likely to have both experienced and witnessed
overdose (Gicquelais et al., 2019). Women are also at higher odds of both experiencing
and witnessing overdose if they report being in a partnership with a man who also uses
drugs (El-Bassel et al., 2019). However, women may be more likely than men to carry
naloxone (Tobin et al., 2018), and to call emergency services in response to an overdose
(Ambrose et al., 2016; Lim et al., 2019), suggesting that women who may witness
overdose are also willing to take preventive and responsive measures. Thus, both
experiencing and witnessing overdose are important events to examine in the lives of
women who use drugs, with critical implications for health and well-being of women and
their communities.
3.1.2

Individual-level Risk Factors in Women’s Overdose Experiences
Much research to date has focused on individual-level factors shaping a person’s

likelihood of experiencing or witnessing overdose. Engaging in injection drug use (IDU),
for example, is a well-documented and significant risk factor for experiencing an opioid
overdose, given that it is a faster and more direct route of administration compared to
other forms of drug consumption (e.g., oral or smoking; Darke & Hall, 2003). However,
research with people who inject drugs has identified other individual-level factors
associated with overdose risk, including opioid expertise, polysubstance use, and
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emotional pain (e.g., depression, a desire to numb or dissociate, or suicidality; Chang et
al., 2019). Women who inject drugs may also be more vulnerable to overdose than men,
given gendered power dynamics in IDU contexts that may limit women’s expertise or
control over equipment and drug supply (Bryant et al., 2010). Furthermore, given that
women who use drugs – particularly those with histories of incarceration – are very likely
to experience co-occurring mental health issues (Bronson & Berzofsky, 2017), women
may also be more likely to experience the depression or emotional pain that may
precipitate overdose. However, the predominant focus on individual-level factors (e.g.,
drug use behaviors, sociodemographic factors) should not overshadow the role that
environmental factors may also play a role in women’s likelihood of experiencing
overdose.
3.1.3

Environmental/Structural Factors in Women’s Overdose Experiences
In addition to individual-level factors, Rhodes and colleagues (2012)

conceptualize environmental/structural factors as part of individuals’ “risk
environments,” defined as “determinants that extend beyond ‘proximal’ individual-level
factors and their behavioral mediators” (p. 206). Building on medical sociological theory
examining social determinants of health, Rhodes and colleagues (2012) highlight how
environmental factors (physical, social, economic, or political) can create “structural
vulnerability” for individuals to experience negative health outcomes. For example,
likelihood of overdose has been found to relate to rurality (Pear et al., 2019), which may
be impacted by regional fluctuations in purity of illicit opioids (Hempstead & Yildirim,
2014). Regional and cultural variations in women’s gendered stigma of substance use
may also exacerbate overdose risk by driving women from high-stigma communities to
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use in more isolated or high-risk settings. Conversely, women’s higher preparedness and
responsiveness in overdose situations (Ambrose et al., 2016; Lim et al., 2019; Tobin et
al., 2018) may make them more receptive to policies expanding naloxone training and
distribution.
CLS involvement is also a critical structural factor, given that incarcerated
individuals are likely to report a prior history of overdose experiences (van Draanen et
al., 2020) and are at significantly elevated risk of overdose following release
(Ranapurwala et al., 2018). Risk of overdose following release from incarceration can be
mitigated by programs supported through environmental/structural-level policies,
including overdose reversal education and naloxone distribution (Malta et al., 2019) and
access to MOUD prior to release (Macmadu et al., 2021). However, while such programs
are not consistently or widely implemented, incarceration remains a critical risk marker
for overdose (Joudrey et al., 2019). Thus, interventions targeting reduction of women’s
overdose risk may have a broader reach if they acknowledge and address factors on a
larger scale, including place, time, and CLS involvement.
3.1.4

Intersectional Overdose Risk Environments
Moreover, individual-level factors may also interact with structural or

environmental elements, compounding or reducing risks. Collins et al. (2019) have
called for an intersectional risk environment framework to explain differential outcomes
for individuals who use drugs across social-structural dimensions. This interactive
relationship between person and environment can also be viewed through the lens of
Zinberg’s (1984) theory of “drug, set, and setting,” which contends that an individual’s
drug use experience is shaped by 1) the drug and its pharmacological action; 2) the
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person’s “set,” including their current psychological state, background, attitudes, and
motivations; and 3) the “setting” in which use occurs, including both physical and social
contexts. Two recent qualitative studies have used this framework to examine women’s
retrospective accounts of overdose experiences, and both found that women were more
likely to attribute their overdoses to drug (e.g., potency/purity) or their “set” at the time
(e.g., grief, emotional trauma, depression), rather than environmental-level “setting”
variables (e.g., returning to an old neighborhood, presence of drug-using partners or
acquaintances; Ataiants et al., 2020a; Lamonica et al., 2021).
Understanding women’s propensity to attribute overdose experiences to
individual-level factors has important implications for factors through which individual
and environment intersect. For example, safe housing, financial stability, and
engagement with SUD treatment services may minimize overdose risk (Park et al., 2020).
From a perspective of individual attributions, it could be proposed that a woman’s
housing, employment, and treatment status are determined by her motivation and
capacity to seek such resources. However, from an environmental perspective, her ability
to be successful is also affected by local availability and quality of jobs, housing options,
or treatment services; transportation options; health insurance enrollment initiatives; and
stigma towards individuals with SUD (Park et al., 2020). Moreover, women with a
history of incarceration face exacerbated overdose risk due to the gendered stigma and
discrimination of previous drug use and CLS involvement, combined with lowered
tolerance after a period of abstinence while in custody, compounded by housing
instability, child custody challenges, and low rates of employment for women at reentry
(Allen et al., 2010; Flower, 2010; Li, 2018). Thus, even though women may be more
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likely to self-center the cause of their overdose experiences (Ataiants et al., 2020a;
Lamonica et al., 2021), it must be acknowledged that many seemingly individual-level
factors are also impacted by larger environmental or structural forces.
3.1.5

What is at Stake: Overdose, Intersectional Risk, and Trauma
The myriad negative physical health outcomes of drug overdose are well-

understood, including pulmonary edema, muscle tissue breakdown, cardiac arrhythmia,
renal failure, brain injury, and death (Zibbell et al., 2019), yet significant evidence has
also linked mental health issues with overdose experiences (van Draanen et al., 2022).
Although the direction of causality for many mental health concerns (e.g., anxiety or
depression) is unclear, a compelling case may be made for overdose experiences as a
contributing factor to symptoms of PTSD. Indeed, witnessing or experiencing an
overdose may be itself a form of trauma, consistent with DSM-5 criteria for PTSD,
including experiencing or witnessing actual or threatened death or serious injury (APA,
2013). Recent research has highlighted associations between overdose experiences and
PTSD symptoms as a particular concern for women, especially those with intersectional
risk factors, such as transactional sex work or CLS involvement (Ataiants et al., 2020b;
El-Bassel et al., 2019; Lee et al., 2020; Schneider et al., 2021). Although all studies to
date have used cross-sectional designs and definitive causal links have not yet been
established, authors of a recent qualitative study reported that “witnessing an overdose
was often vividly described as a time when participants reported ‘being scared,’ ‘freaking
out,’ ‘panicking,’ or ‘freezing’” (p. 7, Nolte et al., 2022).
While physical health consequences are limited only to the individual
experiencing the overdose, mental health consequences – particularly trauma-related –
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can affect both those who experience and witness the overdose. However, potential
adverse emotional consequences of being present during an overdose may be lessened if
women feel trained, prepared, and empowered to respond. Evidence-based trauma
recovery approaches for women often leverage empowerment frameworks to mitigate
psychological distress and increase women’s sense of self-efficacy, self-esteem, and hope
for the future (East & Roll, 2015; Fallot & Harris, 2002; Masin-Moyer et al., 2022).
Indeed, one qualitative study with syringe exchange clients reported that participants felt
empowered by their ability to administer naloxone and save lives (Rochester &
Graboyes, 2020), yet no research to date has quantitatively examined whether naloxonerelated knowledge may be negatively associated with overdose-related trauma.
Harm reduction frameworks, commonly cited in support of overdose prevention
strategies, often employ an individual-level focus to support a “low-threshold access to
services” (Marlatt, 1996, p. 786), aligning with the harm reduction strategy to “meet
people where they’re at” (SFAF, 2020). Although this tactic may empower individuals to
prevent and reverse overdose, over-emphasis on individual agency should not
overshadow structural and environmental factors that shape overdose risk. This
distinction has further implications for expectations of responsibility: much overdose
response is tasked to those individuals who use drugs, who are most likely to be directly
affected and in a position to take immediate action. However, communities, public health
agencies, carceral systems, and legislators can also address systemic risk factors and
structural inequalities that create or reduce risk to create more integrated, sustainable
change. Nonetheless, research rarely examines multiple levels of overdose-related risk
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factors simultaneously, in context of one another, despite the practical implications of this
strategy.
3.1.6

Current Study
Women’s likelihood of both witnessing and experiencing overdose have critical

implications for mental health, trauma, and mortality, yet research to date has not
sufficiently examined factors associated with overdose experiences and overdose reversal
training among populations of women who use drugs, particularly those with CLS
involvement. Furthermore, there is a dearth of overdose research examining risk or
protective factors across multiple levels of influence to inform both individual and
systemic/environmental intervention efforts. Thus, the aims of this second paper are
three-fold: 1) to describe a sample of women entering corrections-based SUD treatment
programs in Kentucky, including experiences related to overdose, overdose reversal, and
naloxone sourcing knowledge when not incarcerated; 2) to examine individual-,
intersectional-, and environmental-level factors as independent correlates of overdoserelated variables, using logistic regression models; and 3) to examine if overdose-related
variables are moderators of the ancillary outcome variable of interest, PTSD, while
controlling for individual-, intersectional-, and environmental-level factors.

3.2
3.2.1

Methods
Participants & Procedures
This study uses secondary data collected as part of the Criminal Justice Kentucky

Treatment Outcome Study (CJKTOS; see Staton-Tindall et al., 2009), an ongoing statefunded evaluation of Department of Corrections (DOC)-based SUD treatment programs
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(i.e., in jails, prisons, or community-based programs). All programs are six months in
duration and follow a modified therapeutic community (TC) model (De Leon, 2000).
Although some participants may be incentivized to enter and complete treatment (e.g.,
offered release to parole upon completion of a program), participants may elect not to
participate in programming and can withdraw at any time.
At treatment entry, all participants complete a biopsychosocial assessment
interview with a DOC clinician, including sociodemographic information, history of
substance use, and behaviors during the 12 months prior to their current incarceration
period. Participants are asked for their permission to upload data from interviews to a
confidential server at the university’s research center for purposes of data management
and analysis. Consent for this data collection and use is a routine part of treatment entry
when state or block grant funds are used to support program costs. Data collection and
storage was conducted in compliance with HIPAA regulations to secure confidentiality of
protected health information and all procedures were approved by the University’s
Institutional Review Board (IRB).
All data were obtained from baseline assessments completed after September
2019, at which point the assessment instrument was expanded to include the outcome
variables of interest for the present paper (experiencing overdose, witnessing overdose,
and knowing where to obtain naloxone when not incarcerated). Between September
2019 – January 2022, 11,236 individuals have completed a baseline assessment, 1,935 of
whom were women (17.2%). These assessments were completed with women in five
jails (n = 702), two prisons (n = 540), and two community-based residential treatment
programs attended by participants while under DOC custody or supervision (n = 693).
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Given that long-term residential TC programs for community corrections are not a
nationally prevalent model compared to carceral treatment options (Belenko et al., 2013),
and due to heightened overdose risk associated with incarceration (van Draanen et al.,
2020), the present study included only women receiving treatment while incarcerated in
prison or jail settings, resulting in a final sample of N = 1,242.
3.2.2

Measures
Analyses for the present study include individual-level variables, variables

representing the intersection of person and environment, and environmental-level
variables.
3.2.2.1 Individual Level
Participants were asked to report age in years, Hispanic or Latina ethnicity
(1=yes, 0=no), and race, selecting all categories that applied of White, Black, American
Indian/Alaskan Native, Asian/Pacific Islander, or Other. Participants who selected more
than one racial category or “Other” were recoded as “multiracial or other.” For regression
models, race/ethnicity was recoded as non-Hispanic White (=1) vs. all other
races/ethnicities (=0).
Respondents also described their history of substance use, including lifetime IDU
(0=no, 1=yes) and severity of opioid use disorder (OUD) symptomology during the 12
months PTI (as measured using DSM 5 criteria; APA, 2013), given that opioid use is
currently implicated in the majority of drug-involved overdose deaths (Hedegaard et al.,
2020; NIDA, 2021). Specifically, individuals endorsing 2-3 OUD symptoms were coded
as having “mild OUD,” 4-5 symptoms as “moderate OUD,” and 6 or more as “severe
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OUD,” out of 11 possible symptoms. For regression models, OUD criteria was recoded
as 1 for any severity level of OUD, 0 for no OUD, given low variance across levels of
OUD severity (94.1% of women meeting OUD criteria were coded as “severe”).
Finally, participants were asked about their experiences with various mental
health problems during the 12 months prior to incarceration (PTI), including whether
they had experienced any serious depression, serious anxiety or tension, or thoughts of
suicide (all coded as yes=1, no=0). In the baseline assessment, participants were also
asked to respond to DSM 5 diagnostic criteria for post-traumatic stress disorder (PTSD;
APA, 2013), which was included both as an independent variable and an ancillary
outcome of interest for the present study. These criteria included: exposure to actual or
threatened death, serious injury, or sexual violence; presence of intrusion symptoms (e.g.,
recurrent distressing dreams); persistent avoidance of stimuli associated with the event;
negative alterations in cognitions and mood (e.g., feelings of detachment or estrangement
from others); and marked alterations in arousal and reactivity (e.g., exaggerated startle
response). Individuals who endorsed all criteria or symptoms (including two or more
alterations in both cognitions/mood and arousal/reactivity) and indicated that the
disturbance lasted for at least one month, with clinically significant distress or
impairment, were considered consistent with clinical thresholds for PTSD and coded as 1,
all others as 0.
3.2.2.2 Individual-Environmental Intersection Level
Other variables are affected by both individual- and environmental-level factors.
Employment, for example, is shaped both by an individual’s previous employment
history and current motivation and capacity to seek work, as well as local availability and
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access to appropriate employment opportunities. For the present analyses, employment
status was recoded dichotomously to indicate whether the participant was employed at
least part-time for most of the 12 months PTI (yes=1, no=0). Also included in this
category are education (achieved a high school diploma or GED=1, no diploma/GED=0)
and whether participants considered themselves to be homeless at any point during the 12
months PTI (yes=1, no=0).
Measures are also included for the participant’s self-reported lifetime SUD
treatment history, which is comprised of five dichotomous variables (1=yes, 0=no)
including ever received any type of SUD treatment, ever received inpatient or residential
treatment, ever received outpatient treatment, ever received withdrawal management
modalities, and received medication for addiction treatment [MAT] during the 12 months
PTI. Participants also reported whether they were familiar with treatment resources in
their area, familiar with syringe exchange programs in their area, and if they had ever
used a syringe exchange program in the state (all variables coded: yes=1, no=0).
3.2.2.3 Environmental Level
The first environmental-only factor is timing of arrest. Given that the baseline
interview asks women to describe their behaviors and experiences during the 12 months
PTI, arrest timing situates the temporal context of the 12-month reference period. In the
past decade, Kentucky has seen notable fluctuations in many factors which may impact
women’s experiences with overdose, including decreased opioid analgesic prescribing
(key legislation passed in 2012; Luu et al., 2018) and increased exposure to potent
synthetic opioids (e.g., rising street fentanyl prevalence beginning in 2013; Slavova et al.,
2017). In 2015, Kentucky also saw implementation of syringe exchange programs
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(Bixler et al., 2018) and expanded access to naloxone through pharmacies (Palmer et al.,
2017), the same year the easy-to-administer nasal spray formulation of naloxone became
FDA-approved (FDA, 2015). Thus, timing of arrest is included to control for
environmental differences in women’s pre-incarceration experiences. Women are asked
how many months they have been in custody prior to treatment entry; this variable was
then subtracted from the date of treatment entry to calculate an approximate date of
arrest. Date of arrest was then subtracted from the date on which data were downloaded
from the University’s secure server (January 14, 2022) to achieve a value in days, with
smaller values indicating women who were arrested more recently, and larger values
indicating women whose 12-month PTI reference period was anchored in the more
distant past. Additionally, the institution at which each participant was entering treatment
(recorded by DOC clinicians completing assessments) was coded as jail (=0) or prison
(=1). Given that women incarcerated in prisons are typically serving longer sentences
related to more severe crimes and/or a greater number of prior convictions compared to
women incarcerated in jails (BJS, n.d.), treatment institution was included as an indicator
of CLS involvement and length of incarceration.
Also at the environmental level, women were asked which county they were
arrested in for their current conviction, which was dichotomized as metro (=0) or nonmetro (=1) using the United States Department of Agriculture’s (USDA) Rural-Urban
Continuum Codes (i.e., “Beale codes;” USDA, 2020). County of conviction was also
recoded as Appalachian (=1) or not (=0) based on designations provided by the
Appalachian Regional Commission (ARC, n.d.).
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3.2.2.4 Overdose Variables
Regarding their history of experiences related to overdose and overdose reversal,
women were asked to self-report: 1) lifetime history of opioid overdose; 2) having ever
witnessed someone else overdose; and 3) whether they knew where to obtain naloxone
when not incarcerated (i.e., naloxone sourcing knowledge). All variables are
dichotomously coded as 0=no, 1=yes; number of lifetime overdoses experienced and
witnessed are also presented as continuous measures for context.
3.2.3

Analytic Plan
Descriptive statistics were calculated for all variables, including means, standard

deviations, and proportions. Next, a series of logistic regression models were performed,
with dependent variables as 1) having ever witnessed an overdose, 2) having ever
experienced an overdose, and 3) knowing where to obtain naloxone. A total of 34
participants refused to answer one or more overdose-related variables and were included
in the descriptive profile of the sample but excluded from regression models. For each
model, independent variables at each level of influence (i.e., individual, intersectional, or
environmental) were included, as well as other overdose variables. Using this method,
results were examined to determine which variables are significantly associated with each
dependent variable of interest, controlling for variables across all levels of influence, as
well as the statistical impact of other types of overdose experiences. Addressing potential
multicollinearity, no variable was correlated above r=0.51 with any other variable,
including the overdose variables (Pearson’s r for each pairing are as follows:
witness/experience=0.26; experience/know where to get naloxone=0.24; witness/know
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where to get naloxone=0.39). For context, a correlation coefficient of 0.8 is the most
commonly used threshold in multicollinearity diagnostics (Vatcheva et al., 2016).
Lastly, to explore the potential of a moderated relationship between overdose
variables and meeting PTSD criteria, three additional logistic regression analyses were
performed with PTSD as the dependent variable. Specifically, the three models
examined interactions between 1) witnessing/experiencing overdose, 2) experiencing
overdose/knowing where to get naloxone, and 3) witnessing overdose/knowing where to
get naloxone. These models aimed to determine whether both witnessing and
experiencing overdose may have a multiplicative effect, increasing likelihood of PTSD
(Model 1), and whether naloxone sourcing knowledge might reduce risk of PTSD among
women who had witnessed or experienced overdose (Models 2 & 3). All covariates were
retained from previous models, to control for individual, intersectional, and
environmental levels of influence alongside interaction terms from each pair of overdoserelated variables. All analyses were performed with Stata 15.

3.3
3.3.1

Results
Descriptive Profile
As shown in Table 3.1, on average, women entering SUD treatment programs in

jail or prison in Kentucky were 36.2 years old, 91.1% identified as White and 98.1% as
non-Hispanic. Mental health problems during the 12 months PTI were prevalent,
including depression (59.1%), anxiety (60.9%), or suicidal ideation (20.9%), and almost
half of women met diagnostic criteria for PTSD (45.2%). Most women had previously
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injected drugs (63.0%), and while 38.5% reported no opioid use in the 12 months PTI,
49.1% met criteria for “severe” OUD (endorsement of six or more of 11 symptoms).
Although most women had obtained at least a high school diploma or GED
(74.6%), less than half were employed during the 12 months PTI (42.9%) and 44.2%
considered themselves to be homeless at some point during that time. Additionally,
many women were aware of treatment resources and SEPs in their communities (48.8%
and 46.5%, respectively), yet only 16.8% of women had previously used a SEP in their
state. However, three-fourths of women had previously participated in a SUD treatment
program (75.3%), including one in five who reported having received some type of MAT
in the 12 months PTI (20.3%). Just over half of women (54.0%) were arrested in a
county designated as “non-metro” and 33.0% in an Appalachian county. Finally, 43.5%
of women were entering treatment in a prison setting (vs. 56.5% in jail), and women had
been arrested on average 3.4 years (1,237.3 days) prior to the reference date of January
14, 2022, meaning that the average date of arrest was approximately August 27, 2018.
Overdose experiences were prevalent among the present sample, with 44.4%
having overdosed in their lifetime, on average 4.0 times (range=1–100, median=2), while
56.7% had witnessed another person overdose, on average 6.7 times (range=1–500,
median=3). Less than half of women (42.6%) reported that they would know where to
get naloxone when not incarcerated.
3.3.2

Intersectional Risk Environment Factors as Independent Correlates of Overdoserelated Variables
To address the second aim of the study, a series of logistic regression models

examined independent variables at the individual, intersectional, and environmental level
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as correlates of experiencing or witnessing an overdose, and of knowing where to obtain
naloxone. Results are shown in Table 3.2.
3.3.2.1 Nonfatal Overdose Experience
At the individual level, having previously experienced a nonfatal overdose was
independently associated with younger age (AOR=0.98, p=.009), lifetime IDU
(AOR=2.58, p<.001), and meeting DSM-5 criteria for OUD (AOR=2.11, p<.001).
Women had greater odds of reporting a previous overdose if they met criteria for PTSD
(AOR=1.40, p=.025) and were over twice as likely if they had experienced suicidal
thoughts during the 12 months PTI (AOR=2.28, p<.001). At the intersectional level,
lifetime overdose was associated with experiencing homelessness during the 12 months
PTI (AOR=1.36, p=.033) as well as a lifetime history of SUD treatment (AOR=1.89,
p<.001). At the environmental level, experiencing overdose was independently
correlated with having been arrested in an Appalachian county (AOR=1.57, p=.008).
Finally, lifetime overdose was significantly associated with having previously witnessed
an overdose (AOR=1.51, p=.006) and naloxone sourcing knowledge (AOR=1.43, p=.022).
3.3.2.2 Witnessing Overdose
Similar to personal overdose experiences, at the individual level, having
witnessed an overdose was associated with younger age (AOR=0.97, p=.001), having
injected drugs (AOR=1.77, p<.001), and meeting OUD criteria (AOR=1.35, p=.041).
Witnessing an overdose was also independently correlated with over twice the odds of
meeting criteria for PTSD (AOR=2.46, p<.001). At the intersectional level, women were
more likely to report having seen someone overdose if they were aware of SEPs in their
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local area (AOR=1.67, p=.001) and had received MAT in the 12 months PTI (AOR=1.52,
p=.026). At the environmental level, women were more likely to have witnessed an
overdose if they were incarcerated in prison (vs. jail; AOR=1.42, p=.018). Lastly, having
witnessed an overdose was uniquely correlated with having previously experienced an
overdose (AOR=1.50, p=.007) and knowing where to obtain naloxone (AOR=4.06,
p<.001).
3.3.2.3 Naloxone Sourcing Knowledge
In the third model, as in the first two models, women who reported knowing
where to obtain naloxone were also more likely to report lifetime IDU (AOR=1.64,
p=.003) and to meet OUD criteria (AOR=2.02, p<.001). However, women who met
criteria for PTSD were significantly less likely to know where to get naloxone
(AOR=0.65, p=.007). At the intersectional level, naloxone sourcing knowledge was
independently associated with awareness of local treatment resources (AOR=1.57,
p=.002) and SEPs (AOR=2.40, p<.001), as well as receipt of MAT in the 12 months PTI
(AOR=1.56, p=.014). At the environmental level, women were less likely to know where
to get naloxone if they were entering treatment in prison (compared to jail; AOR=0.53,
p<.001), but more likely if they had been arrested more recently (AOR=0.98, p=.010). To
illustrate, calculated predictive margins suggest that for each additional year prior to 2021
in which a woman’s arrest occurred, her probability of knowing where to obtain naloxone
is 2.0 percentage points lower on average (holding all other variables at their means).
Finally, naloxone sourcing knowledge was uniquely associated with having personally
experienced (AOR=1.44, p=.020) or witnessed (AOR=4.06, p<.001) a prior overdose.
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3.3.3

Moderated Relationships Between Overdose Experiences, Naloxone Sourcing
Knowledge, and Trauma
To address the third aim of the present study, a series of logistic regression

models were performed with a dependent variable of meeting criteria for PTSD, to
examine potential interactions between 1) witnessing/experiencing overdose, 2)
experiencing overdose/knowing where to get naloxone, and 3) witnessing
overdose/knowing where to get naloxone. Models 1 and 2 are not presented due to
interaction terms that were nonsignificant.
In the third moderated logistic regression model (presented in Table 3.3), women
were less likely to meet criteria for PTSD if they identified as White, non-Hispanic
(AOR=0.44, p=.001), but more likely if they also reported depression (AOR=2.28,
p<.001), anxiety (AOR=2.81, p<.001), or suicidal thoughts (AOR=1.97, p<.001) during
the 12 months PTI. At the intersectional level, PTSD symptomology was positively
associated with homelessness (AOR=1.46, p=.008) and knowledge of local treatment
resources (AOR=1.33, p=.046) but negatively associated with receipt of MAT during the
12 months PTI (AOR=0.68, p=.026). No variables at the environmental level were
significantly associated with PTSD.
Among overdose variables included in the model, PTSD was uniquely associated
both with having personally experienced a nonfatal overdose (AOR=1.49, p=.008) and
having witnessed someone else overdose (AOR=3.73, p<.001). Although there was no
main effect of knowing where to get naloxone, the interaction term between witnessing
an overdose and knowing where to obtain naloxone was significantly associated with
women’s likelihood of reporting symptoms consistent with PTSD (AOR=0.29, p<.001).
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To illustrate the relationship between witnessing overdose, knowing where to
obtain naloxone, and PTSD, predictive margins were calculated to describe odds of
meeting criteria for PTSD at each level of the dichotomous interaction variables, holding
all other covariates in the model constant (Table 3.4). Specifically, women with no
knowledge of where to get naloxone and no history of witnessing overdose were the least
likely to meet PTSD criteria (AOR=0.76), followed by women who had not witnessed
overdose but knew where to get naloxone (AOR=1.20), and women who had witnessed
overdose and knew where to obtain naloxone (AOR=1.43). Women who had seen
someone else overdose, but did not know where to get naloxone, had over three times the
odds of meeting criteria for PTSD (AOR=3.34), holding all other variables constant.

3.4

Discussion
This paper has made an important contribution to the literature not only by

focusing on overdose experiences and naloxone sourcing knowledge among incarcerated
women with a history of substance misuse, critical and interrelated issues in an
understudied population, but also by framing the problem through a more holistic lens.
Rather than relying solely on individual-level explanations of risk, this paper has utilized
a “risk environment” lens to highlight the importance of including environmental and
intersectional factors in risk models. Understanding how diverse factors play a role in
shaping women’s overdose risk environments will allow for future interventions to utilize
more preventive strategies, to target and tailor approaches to reach the most vulnerable,
and to more effectively reduce future overdose deaths. Additionally, by focusing on the
relationship between overdose experiences, naloxone sourcing knowledge, and PTSD
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symptomology, this study highlights overdose as a traumatic event and presents naloxone
access education as a possible mitigating factor for future overdose-related trauma.
The first aim of the study was to describe a unique sample of women seeking
corrections-based SUD treatment while incarcerated in jail or prison in Kentucky, with a
focus on overdose experiences and knowledge of where to obtain naloxone when not
incarcerated. Research on comparative samples is extremely limited: in one study of
individuals who used opioids and were receiving residential treatment through DOC
diversion in Michigan, 75.5% of women had ever experienced an overdose, 84.1% had
witnessed an overdose, and 66.9% had heard of naloxone (Gicquelais et al., 2019).
Given that the present study included women with any type of SUD, not just those who
had used opioids, it is unsurprising that the Michigan study reported higher rates. Other
studies have examined overdose experiences in high-risk community samples (e.g.,
recruited from harm reduction sites; Otachi et al., 2020), or overdose experiences postrelease from jail or prison among formerly incarcerated individuals (see Joudrey et al.,
2019), making comparison to the present study difficult. However, the lack of
comparable prior research highlights the important contribution of this study, by
describing these experiences in a more inclusive sample of incarcerated women with a
history of SUD, rather than OUD alone. Individuals who use any substances may be
likely to witness overdose – and thus be in a position to intervene – due to social ties to
others in communities of people who use drugs. Additionally, although the majority of
overdose fatalities involve opioid use, overdose deaths involving stimulants have also
risen in recent years (Hedegaard et al., 2020; NIDA, 2021) although stimulant overdose
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experiences and response techniques are less-well understood (Mansoor et al., 2022) and
remain an important area for future research.
The second aim of the study was to examine individual-, intersectional-, and
environmental-level factors as unique correlates of overdose-related variables. At the
individual level, lifetime IDU and meeting OUD criteria for use patterns in the 12 months
PTI were related to experiencing and witnessing overdose, consistent with prior research
(Darke & Hall, 2003). These factors were also associated with where to obtain naloxone,
suggesting that local targeted distribution and education efforts with at-risk populations
may be impactful. However, the individual-level findings related to women’s mental
health are notable, namely the heightened risk of reporting lifetime overdose among those
who experienced suicidal thoughts in the 12 months PTI, as well as the relationship
between witnessing or experiencing an overdose and meeting criteria for PTSD.
Qualitative research has evidenced a strong link between women’s emotional pain and
overdose experiences, whether the overdose is an intentional attempt at suicide or a lack
of caution or preventive measures resulting from a diminished desire to sustain life
(Ataiants et al., 2020a; Chang et al., 2019; Lamonica et al., 2021). Given the crosssectional nature of the data, it should also be acknowledged that prior nonfatal overdose
experiences may increase women’s likelihood of suicidal ideation, although no research
to date has examined this possibility.
Regarding relationships between overdose variables and PTSD, few studies to
date have examined this association. In two studies (Lee et al., 2020; Schneider et al.,
2021), PTSD was uniquely associated with having personally experienced overdose, a
finding that was replicated in the present study. However, the present study also found
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that PTSD was independently correlated with having witnessed an overdose, which is
congruent with some prior research (Nolte et al., 2022) but not all studies (Schneider et
al., 2021). Additionally, no studies to date have examined associations between naloxone
sourcing knowledge and PTSD symptomology, despite research suggesting that capacity
to reverse overdose is empowering for those who use drugs (Rochester & Graboyes,
2020) and evidence that empowerment-based trauma recovery services can mitigate
women’s psychological distress (East & Roll, 2015; Fallot & Harris, 2002; Masin-Moyer
et al., 2022). Given the high prevalence of traumatic stress and other mental health
concerns among women who use drugs (Bronson & Berzofsky, 2017), future research
should examine the mechanism of the relationship between overdose experiences and
PTSD alongside other forms of trauma experienced by CLS-involved women who use
drugs to improve trauma-informed care.
At the intersectional level, findings varied across the three models. Personal
overdose experience was associated with homelessness prior to incarceration, a
relationship that has been highlighted in recent research calling for a need to address
disparities along the social and structural determinants of health contributing to both
(Doran et al., 2022). Overdose experience was also associated with a lifetime history of
previous SUD treatment, which may simply reflect a more extensive substance use
history; it is possible that both overdoses and treatment episodes would become more
likely to occur as an individual continues to use substances over a longer period of time.
However, nonfatal overdose has also been associated with increased likelihood of
substance use treatment following the overdose event (Karmali et al., 2020). This
association also highlights the consideration that probability of overdose increases among
67

individuals exiting environments in which their access to drugs is restricted and tolerance
becomes lowered (e.g., release from residential treatment or jail; Ranapurwala et al.,
2018).
Also at the intersectional level, receipt of MAT in the 12 months PTI, as well as
awareness of local SEPs, were both associated with a higher likelihood of having
witnessed an overdose. However, these factors were also associated with higher odds of
knowing where to obtain naloxone, as was knowledge of local SUD treatment resources.
Kentucky’s recent expansion of naloxone access through pharmacies (Palmer et al.,
2017) and syringe exchange programs (Bixler et al., 2018) has likely contributed to a
more widespread awareness of where naloxone can be obtained, information which may
also be shared through resources from local treatment programs, including for MAT.
From an intersectional level, this relationship suggests that women are more likely to
know where to get naloxone if they choose to engage with local SUD resources, but also
if such resources are available and accessible in their communities.
At the environmental or systemic level, few variables were significant across the
three models. Of note, women arrested in more recent years had significantly higher
odds of knowing where to obtain naloxone. Similarly, women who were participating in
jail-based treatment were significantly more likely to know where to obtain naloxone
than women in prison-based treatment, who are typically incarcerated for longer periods
(BJS, n.d.), and thus may have been arrested during earlier years of the sample. Although
the nasal spray formulation of naloxone became available in 2015, the same year that
Kentucky approved more flexible prescribing and dispensing protocols for the overdosereversal drug (FDA, 2015; Palmer et al., 2017), expansion of naloxone education,
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distribution, and outreach efforts are still ongoing. Future research should examine
whether this higher awareness of naloxone sourcing translates to lower rates of overdose
fatalities in CLS-involved populations in future years, particularly during high-risk
reentry periods. Additionally, women who were arrested in an Appalachian county were
more likely to report having experienced an overdose, although no differences were
observed for witnessing overdose or knowing where to obtain naloxone based on county
of arrest. Recent data indicates that while overdose mortality is 55% higher in
Appalachian vs. non-Appalachian counties, this disparity is even greater for women than
for men (74% vs. 36% higher than non-Appalachian U.S.; Meit et al., 2020). Resource
allocation for overdose risk reduction in Appalachian regions should be a priority, to
support initiatives such as the Appalachian Regional Commission’s INvestments
Supporting Partnerships in Recovery Ecosystems (INSPIRE; arc.gov/sud/).
The final aim of this study was to explore potential moderating relationships
among overdose-related variables, relative to women’s self-reported symptoms of
trauma. The finding that women were significantly more likely to meet criteria for PTSD
at entry to corrections-based treatment if they had witnessed an overdose, but did not
know where to obtain naloxone, is notable and has not been examined in prior research.
It does, however, align with qualitative research suggesting that possessing the
knowledge and confidence to administer naloxone when needed is empowering to people
who use drugs, particularly in context of the marginalization and disempowerment they
face in other areas of their lives (McAuley et al., 2018; Rochester & Graboyes, 2020).
Although the present study only examined knowledge of where to obtain naloxone, not
receipt of training or prior overdose reversal experience, it is possible that mere
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awareness of where to access naloxone is enough to reduce women’s feelings of
helplessness and powerlessness after witnessing a life-threatening or fatal event. In this
way, naloxone awareness, education, and distribution efforts may have a significant
positive impact: not only by preventing physical injury and death among people who
experience overdose, but also by minimizing negative mental health outcomes among the
myriad other individuals who may witness overdose.
Findings are subject to limitations. The use of cross-sectional data precludes
causal inference. Also, women in the present study were both incarcerated and seeking
SUD treatment services; therefore, findings may not be generalizable to CLS-involved
women who were not eligible for/interested in SUD treatment, or those who were
arrested but offered drug court, community supervision, or diversion (including
community-based treatment). Additionally, the low proportions of racial/ethnic minority
women in this treatment-seeking, incarcerated sample do not reflect the
overrepresentation of Black and Latina women in Kentucky jails or prisons more
generally (Vera Institute of Justice, 2019). Future research is needed to examine if this
difference reflects a disparity in corrections-based treatment access, a gap in culturallyinformed services, and/or a difference in need for SUD treatment among incarcerated
women. This study is further limited by a lack of information around witnessing
overdose (e.g., were overdoses fatal or nonfatal) and specificity of recent overdose events
(e.g., 12 months PTI) rather than lifetime, to align with other measures. More
information related to recent overdoses would potentially allow for inclusion of eventlevel environmental variables (e.g., neighborhood/setting in which overdose occurred,
proximity to harm reduction and treatment services, degree of police presence,
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community socioeconomic status) that could expand environmental/structural risk
analysis. Finally, all data are self-reported and collected by DOC clinicians, and thus may
be subject to rapport or recall bias, although prior research has suggested that this type of
self-report data gathered from individuals who use drugs is valid (Darke, 1998; Denis et
al., 2012).
Despite these limitations, the present study has made a valuable contribution by
examining experiences with overdose and naloxone sourcing knowledge among women
entering corrections-based SUD treatment. Overdose risk is rarely assessed at
intersectional and environmental levels, yet this study found several significant
relationships, many related to awareness and utilization of local SUD resources prior to
incarceration. These findings highlight the importance of treatment and recovery support
centers as avenues to provide harm reduction education and services, particularly in areas
where women may be more likely to experience overdose (e.g., Appalachian counties).
Finally, the relationships between mental health issues and overdose experiences are
particularly relevant for this study population, given the prevalence of mental health
concerns among incarcerated women with a history of substance use (Bronson &
Berzofsky, 2017). However, it is promising that naloxone sourcing knowledge is
associated with a lower likelihood of PTSD among women who have witnessed
overdose, and more research is needed to understand women’s experiences of overdoserelated trauma. Knowledge of women’s resilience, coping, and construction of
meaningful narratives around overdose can inform effective future interventions to
mitigate negative outcomes for women’s physical and mental health. Finally, given that
women are more likely to attribute overdose to individual-level factors (Ataiants et al.,
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2020a; Lamonica et al., 2021) – which has the potential to exacerbate feelings of guilt or
shame – highlighting the role of intersectional or environmental factors to women who
have witnessed or experienced overdose may be yet another means to lessen the impact
of overdose-related trauma.
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Table 3.1 Descriptive profile (N = 1,242)
Individual level
Age (years)
Race
White
Black/African-American
American Indian or Alaskan Native
Asian or Pacific Islander
Other or multiracial
Ethnicity (% Hispanic/Latina)
Mental health
Serious depression PTI
Serious anxiety or tension PTI
Suicidal thoughts PTI
Meets criteria for PTSD
Substance use history
Ever injected drugs
DSM-5 OUD criteria
No opioid use in 12 months PTI
Opioid use but did not meet OUD
criteria
Mild OUD
Moderate OUD
Severe OUD
Individual-environmental intersection level
High school diploma or GED
Employment PTI (% employed at least parttime)
Experienced homelessness PTI
Aware of local syringe exchange programs
(SEPs)
Previously used a SEP
Aware of local treatment resources
History of SUD treatment
Any SUD treatment
Inpatient/residential
Outpatient
Withdrawal management
Received MAT in 12 months PTI
Environmental level
County of arrest
Non-metro (vs. metro)
Appalachian (vs. non-Appalachian)
73

M (SD) /
%

Range

36.2 (8.3)

18 – 67

N

91.1%
4.4%
0.5%
0.2%
3.7%
1.9%

1,132
55
6
3
46
23

59.1%
60.9%
20.9%
45.2%

734
756
260
562

63.0%

782

38.5%
9.3%

478
116

1.4%
1.7%
49.1%

17
21
610

74.6%
42.9%

927
533

44.2%

549

46.5%

577

16.8%
48.8%

209
606

75.3%
65.1%
41.3%
27.9%
20.3%

935
808
513
346
252

54.0%
33.0%

671
410

Table 3.1 (continued)
Days before 01/14/2022 that arrest occurred
Currently entering treatment in prison (vs.
jail)
Dependent variables
Lifetime history of overdose
Number of lifetime overdoses (n=551)
Lifetime history of witnessing someone else
overdose
Number of times witnessed someone
overdose (n=703)
Know where to get naloxone
Note: PTI=prior to incarceration.
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1,237.3
(983.1)
43.5%
44.4%
4.0 (7.7)

65 –
13,044

1 – 100

56.7%
6.7 (21.4)
42.6%

540
551
703

1 – 500
529

Table 3.2 Logistic regression analysis of ever having experienced or witnessed an overdose and knowing where to obtain
naloxone (N=1,208)

Pseudo-R2

Model 1: Ever
Experienced an
Overdose
0.20
AOR
SE

Model 2: Ever Witnessed
an Overdose

Model 3: Know Where to
Get Naloxone

0.20

0.25
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AOR
SE
Individual level
Age
0.98**
0.01
0.97***
0.01
White, non-Hispanic
1.06
0.27
1.39
0.33
Depression
1.06
0.17
0.89
0.15
Anxiety
0.97
0.16
0.78
0.13
Suicidal thoughts
2.28***
0.41
0.92
0.17
PTSD criteria
1.40*
0.21
2.46***
0.38
Ever IDU
2.58***
0.40
1.77***
0.27
DSM-5 OUD criteria
2.11***
0.30
1.35*
0.20
Individual-environmental intersection
HS diploma or GED
1.10
0.17
1.16
0.18
Employment
0.86
0.12
0.97
0.14
Homelessness PTI
1.36*
0.19
1.02
0.15
Aware of local treatment resources
0.95
0.14
0.82
0.12
Aware of local SEPs
1.28
0.19
1.67***
0.25
Lifetime SUD treatment
1.89***
0.32
1.12
0.18
MAT in 12 months PTI
1.14
0.20
1.52*
0.29
Environmental level
Non-metro county
0.78
0.12
0.78
0.13
Appalachian county
1.57**
0.26
0.85
0.14
Days before 01/14/2022 that arrest occurreda
1.01
0.01
1.01
0.01
Prison (vs. jail)
1.18
0.17
1.42*
0.21
Overdose variables
Ever experienced an overdose
----1.50**
0.23
Ever witnessed an overdose
1.51**
0.23
----Know where to get naloxone
1.43*
0.22
4.06***
0.63
Note: *p≤.05, **p≤.01, ***p≤.001.
a
Days before reference date that arrest occurred is divided by 100 for regression analyses due to large range.

AOR

SE

1.00
1.39
0.84
1.35
0.99
0.65**
1.64**
2.02***

0.01
0.37
0.14
0.23
0.18
0.10
0.27
0.30

1.20
1.19
0.94
1.57**
2.40***
1.35
1.56*

0.20
0.17
0.14
0.23
0.36
0.24
0.28

0.82
0.91
0.98**
0.53***

0.13
0.16
0.01
0.08

1.44*
4.06***
---

0.22
0.63
---

Table 3.3 Moderated logistic regression analysis of meeting criteria for PTSD (N=1,208)
AOR
SE
Individual level
Age
1.00
0.01
White, non-Hispanic
0.44***
0.11
Depression
2.28***
0.35
Anxiety
2.81***
0.44
Suicidal thoughts
1.97***
0.34
Ever IDU
0.76
0.12
DSM-5 OUD criteria
1.00
0.15
Individual-environmental intersection
HS diploma or GED
0.89
0.14
Employment
1.01
0.14
Homelessness PTI
1.46**
0.21
Aware of local treatment resources
1.33*
0.19
Aware of local SEPs
1.16
0.18
Lifetime SUD treatment
1.21
0.20
MAT in 12 months PTI
0.68*
0.12
Environmental level
Non-metro county
1.20
0.19
Appalachian county
0.85
0.14
Days before 01/14/2022 that arrest
1.00
0.01
occurreda
Prison (vs. jail)
1.04
0.15
Overdose variables
Ever experienced an overdose
1.49**
0.23
Ever witnessed an overdose
3.73***
0.71
Know where to get naloxone
1.51
0.39
Interaction term: Ever witness an
0.29***
0.09
overdose X know where to get naloxone
Pseudo-R2
0.19
Note: *p≤.05, **p≤.01, ***p≤.001
a
Days before reference date that arrest occurred is divided by 100 for regression analyses due to
large range.
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Table 3.4 Marginal odds ratios of meeting criteria for PTSD (N=1,208)
Never witnessed an
Ever witnessed an
overdose
overdose
Does not know where to
0.76
3.34
get naloxone
Knows where to get
1.20
1.43
naloxone
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CHAPTER 4. UNDERSTANDING WOMEN’S DRUG USE FOLLOWING CORRECTIONS-BASED
SUBSTANCE USE DISORDER TREATMENT AND COMMUNITY RELEASE: A MIXED
METHODS SOCIAL-ECOLOGICAL ANALYSIS (PAPER 3)
4.1

Introduction
The point of reentry to the community after a period of incarceration presents

many challenges, particularly for women with a history of drug misuse or substance use
disorder (SUD). Maintaining abstinence after release may be an important marker of
success, and indeed, much research has focused on factors that facilitate or support
abstaining from drug use post-incarceration (Kendall et al., 2018; Robbins et al., 2009;
Van Olphen et al., 2009; Yang et al., 2022). However, the ability to make positive
recovery progress, including (but not limited to) sustaining abstinence, involves factors
across multiple systemic levels. Using a social ecological framework (Golden & Earp,
2012; McLeroy et al., 1988), this paper employs a mixed methods design to explore
women’s self-reported assessments of factors playing a role in their recovery, as well as
quantitative analysis of elements at each ecological level and their relationship to
women’s likelihood of drug use during the post-release period.
4.1.1

Defining Post-release Outcomes for Women with SUD
Many terms are used to discuss outcomes from SUD. Recovery is a common

theoretical construct that has been defined as “an ongoing and dynamic process,”
describing “a state of health and functioning that follows the cessation of addictive
substance use, typically involving abstinence from use” (p. 110, Cleveland et al., 2021).
Discourse surrounding this process has evolved over time to incorporate the voice and
perspectives of individuals with lived experience, and non-abstinence-based outcomes are
accepted in many treatment settings (Rosenberg et al., 2020) and are prevalent among

national community samples of individuals with a previous alcohol or drug problem
(Eddie et al., 2022). However, many recovery communities (e.g., 12-step fellowship
organizations, recovery residences, recovery community centers) endorse the belief that,
while abstinence alone is not sufficient for “recovery,” it is a critical component (Costello
et al., 2020; Helm, 2019; Melemis, 2015). The emphasis on this point is not meant to
further the misconception of a recurrence or return to drug use as “failure” (Miller, 2015).
Rather, the use of abstinence vs. drug use as an outcome of interest offers an accessible
and specifically defined distinction that avoids some of the ambiguity and stigma
associated with terms or concepts such as “relapse” (Moe et al., 2022). Nonetheless,
individual trajectories into and away from drug use are complex and nonlinear, and when
dichotomous measures (such as abstinence vs. drug use) are employed, research does not
often incorporate additional qualitative data to contextualize quantitative outcomes, or
examine key factors purposefully selected within multilevel frameworks.
4.1.2

Social Ecological Frameworks
Broadly, social ecological models acknowledge that no single component

determines individual behaviors or outcomes; rather, factors interact across multiple
hierarchical levels of influence to shape risk, protective factors, growth, and choicemaking (Bronfenbrenner, 1979). McLeroy and colleagues (1988) originally identified
five circles of ecological influence, namely intrapersonal (individual), interpersonal
(relational), institutional (organizational), community, and public policy. Although most
subsequent health interventions have remained focused on individual or interpersonal
factors, the application of ecological models to health behavior research has nonetheless
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provided critical support for multilevel interventions and more holistic research study
designs (Golden & Earp, 2012).
In the three decades since it has come into use, the social ecological model has
been frequently adapted to meet the needs of studies which have employed it. For
example, one study examining substance use patterns among high school students chose
to separate “peers” and “family” into distinct interpersonal domains (Connell et al.,
2010). Another, examining risks and risk contexts of HIV epidemics, included “HIV
epidemic stage” (transmission prevalence) at the most macro level (Baral et al., 2013). A
common adaptation is the inclusion of institutional-level factors within the “community”
domain (see CDC, 2021b; WHO VPA, 2021), collapsing the model into four levels rather
than five and minimizing conceptual overlap. Thus, the social ecological model may
serve as a broad conceptual framework that can be modified to address the needs of a
given population or issue. For the present study, a four-level social ecological model will
be utilized: although a discussion of the “policy” level is offered in the conclusion, this
level will be excluded from analysis, given that rapid changes in relevant state and
correctional policies and social factors (e.g., COVID-19) would present challenges in
isolating the unique impact of a given policy change.
4.1.3

The Social Ecology of Women’s Community Reentry Post-Incarceration
4.1.3.1 Intrapersonal (Individual) Level
A substantial body of research has focused on individual-level factors supporting

desistance from drug use and other markers of successful recovery after reentry to
community post-incarceration. The process of women’s reintegration and recovery is
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intertwined with internal processes such as stigma, self-concept, and identity
management (Boppre & Reed, 2021; Gålnander, 2020; Stone, 2016). Individual-level
features such as race/ethnicity can also be linked to structural disadvantage: for example,
women of color experience a myriad of additional intersecting oppressions contributing
to instability, financial challenges, and a sense of pervasive disempowerment that may
challenge abstinence efforts at reentry (Garcia-Hallett, 2019). Finally, intrapersonal
issues such as mental health problems can create substantial barriers to building and
maintaining “recovery capital,” or resources used to initiate and maintain recovery
(Cleveland et al., 2021), such as stable housing and income (Andersson et al., 2019;
Flynn et al., 2004). Thus, odds of desistance from drug use can be shaped by a woman’s
sense of identity, internal psychological processes, and demographic features, even
before considering other external factors.
4.1.3.2 Interpersonal Level
Relational theory, a foundational perspective of the gender-responsive
correctional services movement (see Zweben, 2011), positions relational connection and
disconnection as central to women’s psychological growth (Covington & Surrey, 1997).
Thus for women in particular, relationships with others may have a crucial impact on
ability and/or motivation to abstain from drug use. For example, positive social ties may
mitigate the risk of a return to drug use (Arditti & Few, 2008), including one-on-one
relationships with 12-step sponsors and other women in recovery (Rush, 2002).
Conversely, perceived stigma and lack of acceptance from others can damage women’s
feelings of self-efficacy and self-worth (van Olphen et al., 2009). Findings from
qualitative research confirm that women’s positive relationships are an important source
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of emotional, social, and material support during the community reentry process, and that
rebuilding damaged relationships may be an important part of women’s desistence
narratives and abstinence from drug use (Leverentz, 2014). However, relationships –
especially with intimate partners – may also be a source of risk for incarcerated or
formerly incarcerated women, involving shared drug use, risky sexual behavior, and
feelings of low relationship power and self-worth (Staton-Tindall et al., 2007; Staton et
al., 2017). Similarly, while the role of motherhood and parenting status can be a
powerful motivator for women’s recovery, frustration with unsuccessful efforts to regain
child custody or rebuild strained relationships after incarceration may be a significant
stressor or trigger for return to drug use (Arditti & Few, 2008; Brown & Bloom, 2009;
Gobena et al., 2022; Harp & Oser, 2018; Robbins et al., 2009).
4.1.3.3 Institutional Level
From a sociological perspective, the institutional level of influence can be
considered as an individual’s engagement with formal social organizations or
establishments (e.g., employment, education, healthcare services). This level of influence
may impact recovery processes from two theoretical standpoints: firstly, institutions are
commonly utilized to assist women in meeting functional needs, such as earning income
or addressing health issues. Many women may exit jail or prison and begin their postincarceration recovery journey with few material assets, yet access to these types of
institutional resources can facilitate women’s maintenance of well-being and stability,
thus increasing recovery capital (Cleveland et al., 2021). Secondly, institutional
involvement can also be a deterrent against returning to drug use by acting as an
additional layer of behavioral monitoring and oversight, particularly when institutions
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include the criminal-legal system (CLS; e.g., parole, probation, drug court) and/or child
protective services. Regardless of the mechanism of change, engagement with all of the
aforementioned institutional-level factors have been associated with lower likelihood of
drug use among women (Kendall et al., 2018; Yang et al., 2022).
4.1.3.4 Community Level
For CLS-involved women, the broader social context may also play an important
role in reentry and recovery. For purposes of this paper, the community level draws from
Durkheim’s construct of milieu (1912/2001), representing the collective characteristics of
one’s social environment. Indeed, epidemiologic literature has leveraged this theoretical
concept to explore the collective impact of social environments on health and health
behaviors (Marmot, 1998; Yen & Syme, 1999). Community-level influences may
include affiliations to social groups that support women through a sense of collective
belonging and membership (such as 12-step fellowships; Majer et al., 2011; Moos &
Moos, 2004; Rush, 2002). Although these groups may be structured or organized, they
are distinct from institutional-level constructs in that they serve no concrete material
purpose (for example, in comparison to employment or healthcare services):
belongingness to community is an end of itself, as individuals benefit from the collective
support and identity affirmation provided by a given social environment.
Community may also encompass the influence of residence in a particular
location, such as a town, city, or region. Women returning to rural areas, for example,
may be uniquely impacted by cultural norms of mutual support and loyalty to place
(Keyes et al., 2014; Russ, 2010). These social mores might support or facilitate recovery,
or conversely, could inspire a negative sense of being unable to escape one’s former
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identity or associates, which can make a return to drug use seem inevitable (Beichner &
Rabe-Hemp, 2014; Buer et al., 2016). Similar feelings of entrapment in former
neighborhoods have also been described by women released to urban areas (Binswanger
et al., 2012; Leverentz, 2010), underlining the importance of considering place-based
community factors as influential to recovery processes. In either case, women’s
community context plays a key role in reentry for women with a history of drug use
(Tillson et al., 2022a), yet remains an understudied level of social-ecological influence.
4.1.4

Present Study
The point of community reentry is a critical opportunity for formerly incarcerated

women with a history of drug misuse or SUD, and much research has focused on factors
associated with women’s successful outcomes (Andersson et al., 2019; Flynn et al., 2004;
Staton et al., 2019; Tillson et al., 2022a). However, to date, few reentry studies
examining outcomes related to illicit drug use (e.g., recurrences of use, treatment
initiation) have purposefully included variables or performed targeted analysis across
multiple levels of the social ecological model (Berg & Cobbina, 2017; Bunting et al.,
2018), and none incorporating a mixed-methods framework. Thus, to address these gaps,
the aims of this paper are: 1) to quantitatively compare women who self-reported any
drug use vs. those who did not, along factors at each dimensional level of the social
ecological model; 2) to explore women’s self-reported barriers and facilitating factors for
abstinence, using thematic qualitative analysis of open-ended interview questions; and 3)
to compare findings of qualitative and quantitative analyses to explore ways in which
women’s interpretations of risk and protective factors for drug use post-release differ
from, or support, regression results.
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4.2
4.2.1

Methods
Participants & Procedures
The present study utilizes secondary data obtained through an ongoing state-

funded evaluation of corrections-based SUD treatment programs in one southern state
(Tillson et al., 2022b). Baseline data were collected from women during a
comprehensive biopsychosocial interview completed by trained clinicians at the point of
women’s enrollment in treatment. Treatment occurred while women were incarcerated in
one of six jails or two prisons in the state that offered women’s SUD programming.
Although the larger evaluation study includes women who receive treatment in
community-based settings while under the Department of Corrections (DOC) custody or
supervision, the present study included only women receiving treatment while
incarcerated in prison or jail settings due to the uniqueness of treatment experiences in
carceral environments and the community reentry process (Belenko et al., 2013).
Programs were six months in duration and followed a therapeutic community
model (De Leon, 2000). All women enrolled in treatment between November 2014 and
April 2021, and interviews focused on women’s history of substance use, mental health,
treatment utilization, and criminal history, mostly during the 12-month period prior to
their current incarceration. Although some participants may be offered incentives to
enter and complete treatment (e.g., release to parole upon completion of a program),
participants may elect not to participate in programming and can withdraw from
treatment at any time.
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To be eligible for the follow-up component of the evaluation study, participants
must 1) consent to be contacted for the follow-up interview, 1 2) be released from custody
within the specified time frame for a given fiscal year, 3) provide at least one valid
address and phone number for contact in the community, and 4) have graduated from a
corrections-based SUD treatment program. 2 Eligible participants were randomly
sampled using a stratified methodology to ensure proportionate representation of
participants in each type of treatment setting (e.g., prison or jail), separated by gender.
Follow-up interviews were then conducted over the phone by university research staff
between 10-14 months after women’s release to the community and discussed
participants’ outcomes across a variety of domains, including drug use, employment,
recovery and social supports, physical and mental health, and service utilization. Followup interviews lasted approximately 30-60 minutes and participants were compensated
$20 (incentive was increased to $30 for interviews completed after February 2020).
All follow-up data for the present study were collected between April 2017 and
August 2022. Data include women who completed programs while incarcerated in jail (n
= 234; 55.1%) or prison (n = 191; 44.9%), for a final sample of N = 425. Between fiscal
year (FY) 2017 and FY2022, the aggregated follow-up rate for women from jail and

1

Between March 2016 – October 2022, 74.4% of women entering jail- or prison-based SUD treatment
have consented to participate in the follow-up interview.

2

Of discharges submitted for women who entered jail- or prison-based SUD treatment between March
2016 – October 2022, 65.8% graduated from their program (23.2% were terminated or withdrew
voluntarily, 10.3% were released to continue treatment in the community, and 0.7% were discharged on a
commuted sentence).
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prison SUD treatment programs sampled for inclusion in follow-up interviews was
76.7%. All data from both baseline and follow-up were collected and stored in
compliance with HIPAA regulations to secure confidentiality of protected health
information, and all procedures were approved by the university’s Institutional Review
Board (IRB). Annual reports provided to the public and DOC staff as part of the statefunded evaluation contract include aggregated results, but no individual responses are
shared with DOC representatives.
4.2.2

Measures
4.2.2.1 Social Ecological Variables

4.2.2.1.1 INTRAPERSONAL (INDIVIDUAL) LEVEL
During the baseline interview, participants were asked to self-report age in years,
Hispanic/Latina ethnicity (1=yes, 0=no), and race. For race, participants selected all
categories that applied of White, Black, American Indian/Alaskan Native, Asian/Pacific
Islander, or Other. Participants who selected more than one category or “Other” were
recoded as “multiracial or other.” Also at treatment entry, participants reported how
many days out of the 30 days prior to their current incarceration in which they
experienced “drug problems,” such as “craving, withdrawal, wanting to quit but being
unable, or worrying about relapse.” Participants also rated their self-efficacy to remain
abstinent after release (“how good are the chances that you can get off and stay off drugs
and alcohol?”) on a 5-point Likert scale, recoded as very poor, moderately poor, or
uncertain (=0), versus moderately good or very good (=1).
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At follow-up, participants indicated whether they had any current chronic
physical pain (0=no, 1=yes). Participants also reported the number of days (out of past
30) and months (out of past 12) in which they had experienced any serious depression,
serious anxiety or tension, and cognitive difficulties (trouble understanding,
concentrating, or remembering), all of which were recoded as 0=none, 1=any
days/months, given the sizeable proportions of participants reporting zero days or months
for each mental health indicator. The three mental health indicators were also collapsed
to 0=no mental health issues, 1=any mental health issues for regression analysis due to
high multicollinearity. Finally, participants were asked, “when you were first released
from [jail/prison], which of the following areas did you need help with?” including
medical care, mental health services, SUD treatment, and employment or job training (all
coded as 0=no, 1=yes). For parsimony in the regression model, the three areas of health
needs (mental, physical, and SUD) were also collapsed into a single indicator of 0=no
reentry health needs reported, 1=any needs reported.
4.2.2.1.2 INTERPERSONAL LEVEL
Several variables were included to measure participants’ relationships with others.
At 12-month follow-up, participants were asked to report whether they had a “close
relationship” with romantic or sexual partners, friends, and family members, as well as if
they had a sponsor from a 12-step fellowship such as Alcoholics or Narcotics
Anonymous (AA/NA; 0=no, 1=yes). Although self-help group meeting attendance more
generally was considered as a distinct community-level variable, sponsorship was
included at the interpersonal level due to the direct, one-on-one relationship between
sponsor and sponsee. Additionally, sponsorship was not highly collinear with meeting
88

attendance (endorsed by 37.2% of women who reported attending self-help group
meetings).
Participants were also asked if they had any children under 18, whether they were
living with their minor children at the time of the follow-up, and whether they had any
minor children in someone else’s temporary legal custody (0=no, 1=yes). Women
indicated whether they had spent most of their free time post-release with family (=1) or
not (i.e., with friends or alone; =0). Lastly, participants also rated how much they felt
cared about or supported by important people in their life on a five-point scale, recoded
as “extremely” (the highest rating) =1, all other lower ratings=0, due to over half of
women in the sample selecting the highest rating option.
4.2.2.1.3 INSTITUTIONAL LEVEL
At 12-month follow-up, participants self-reported if they had engaged in any
educational or vocational programs since release (0=no, 1=yes) and provided past-30-day
earnings in U.S. dollars from gross wages, public assistance, disability, and income from
illegal activity. Earnings were used as an indicator for employment or engagement with
other systems (i.e., government assistance) and were recoded as any income received
from a given source (e.g., wages, disability, illegal activity) =1, no income from that
source=0. Participants were also asked whether they had received any treatment for
physical, mental, and behavioral health/SUD during the past 12 months and whether they
had taken any prescribed mental health medication since their release (0=no, 1=yes).
Previous self-reported SUD treatment history was gathered from the baseline interview,
during which participants reported number of previous episodes in inpatient, outpatient,
or withdrawal management modalities, recoded as any previous SUD treatment=1, no
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treatment=0. Finally, CLS involvement was measured by women’s self-reported number
of lifetime convictions, whether women received treatment in jail (=0) or prison (=1), and
total number of months spent incarcerated prior to treatment entry. Women also reported
at follow-up if they had been on community supervision (e.g., parole or probation) since
their release (0=no, 1=yes).
4.2.2.1.4 COMMUNITY LEVEL
At 12-month follow-up, items were included that assessed women’s broader
social environments post-release. To measure group membership or affiliation,
participants were asked whether they had attended any self-help group meetings (e.g., 12step fellowship groups such as AA/NA) and whether their attendance at these meetings
was a requirement of their supervision. These two variables were combined into a single
categorical variable, coded as 0=no meeting attendance, 1=attended under supervision
requirement, 2=attended with no requirement. To assess place-based community
differences, participants also indicated which county they were living in at the time of the
follow-up interview, which was classified as metro (=0) or non-metro (=1) using the
United States Department of Agriculture’s (USDA) Rural-Urban Continuum Codes (i.e.
“Beale codes;” USDA, 2020) and non-Appalachian (=0) or Appalachian (=1) based on
designations provided by the Appalachian Regional Commission (ARC, n.d.).
4.2.2.2 Qualitative Variables
In the 12-month follow-up interview, participants were asked two open-ended
questions relevant to their perceptions of facilitating or risk factors in their post-release
recovery, namely: 1) “what factors are associated with those who are successful after
90

treatment?” and 2) among those who reported any drug use, “what would you say were
the factors that led up to your drug use?” Responses were transcribed verbatim by
research staff.
4.2.2.3 Outcome Variable
The outcome variable of interest was any use of illicit drugs during the 12-month
follow-up period (1=yes, 0=no), to align with data from the second qualitative variable.
4.2.3

Analytic Plan
Descriptive statistics were calculated for all variables, including means, standard

deviations, and proportions. A series of chi-square and t-tests were calculated to compare
women who reported any illicit drug use during the 12 months post-release from
incarceration and those who did not, along variables at each level of the social ecological
model. For chi-square tests with significant results and more than four cells, differences
were explored using post hoc tests of adjusted residuals (values greater than 2.0;
MacDonald & Gardner, 2000). Finally, variables for which significant bivariate
differences existed were entered into a multivariable logistic regression model, to
determine the unique contribution of variables at each level of the social ecological
framework to women’s likelihood of drug use after receiving corrections-based SUD
treatment and being released from jail or prison. To address potential multicollinearity
issues, Pearson’s r was calculated for all variables to be included in the model; the
highest correlation value observed was r=0.32. All analyses were conducted using Stata
15.
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Following quantitative analysis, responses to open-ended follow-up interview
questions were assigned codes representing each level of the social ecological model
using a directed qualitative content analysis (Hsieh & Shannon, 2005). Each response
could be assigned more than one code as appropriate, depending on the complexity of
each participant’s answer. After the first stage of deductive coding, further inductive
analysis was performed to identify themes discussed by women at each social ecological
level. The rigor of using this hybrid deductive-inductive approach to coding and analysis
has been demonstrated through previous qualitative research (Fereday & Muir-Cochrane,
2006). Proportions of women endorsing factors at each social ecological level are
presented for each qualitative item, as well as themes associated with each level and
illustrative quotes. For responses to the question about success after treatment, a series of
chi-square tests were used to compare the presence of factors mentioned at each level
among women who reported drug use and those who did not. Additional counts or
proportions are offered sparingly, as emergent themes generated through inductive
qualitative analysis may be misrepresented by quantification (Hannah & Lautsch, 2011).
Finally, a convergent parallel mixed methods (Kettles et al., 2011) approach was
used. Results from quantitative and qualitative analyses were compared to more fully
understand facilitating and risk factors for women’s successful recovery post-release, as
well as to explore key differences in findings borne out by quantitative analysis and those
identified by women based on their lived experiences.
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4.3

Results
A descriptive profile of the sample is presented in Table 4.1, as well as bivariate

comparisons between women who reported any drug use during the 12-month follow-up
period (38.4%) and those who did not (61.6%). At the individual level, women were
primarily White (93.3%) and non-Hispanic (99.3%), and 36.4 years old on average at the
time of their release from jail or prison. Women who reported any drug use post-release
were significantly younger than those who did not (p = .023). At treatment entry, these
women also reported having been bothered by drug problems for a greater number of
days in the 30 days before incarceration (p = .001) and were less likely to feel
moderately/very good that they could remain abstinent after release (p = .001). At
follow-up, women who reported any drug use were also more likely to report
experiencing cognitive difficulties, depression, and anxiety (all p < .001). Reflecting
back on their reentry experiences, these women were more likely to say they had needed
help with employment (p = .020), substance use treatment or recovery supports (p <
.001), mental health services (p = .001), and care for physical health problems (p = .007).
At the interpersonal or relational level, at follow-up, participants who reported
any drug use were less likely to report having close relationships with friends (p = .003)
or a 12-step fellowship sponsor (p = .002) after release. Women who had used drugs
were also less likely to report living with their minor children at follow-up (p = .001) and
more likely to report having minor children in someone else’s temporary legal custody (p
< .001). These women were less likely to spend free time with family (p < .001) and to
report feeling “extremely” cared about by the important people in their life (p < .001).
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At the institutional level, at the time of follow-up, women who reported drug use
were less likely to have been employed and received past-30-day earnings from wages (p
< .001) and more likely to have gotten income from illegal activity (p = .004). They were
also more likely to report having received SUD treatment (p = .004) and have taken
prescribed mental health medications (p = .018) since their release.
At the community level, women who reported drug use post-release differed from
those who did not by self-help group meeting attendance (e.g., AA/NA). Adjusted
residuals indicated that, compared to expected proportions, women who reported drug
use were more likely to have attended meetings that were required by probation or parole;
those who reported abstinence were more likely to have attended meetings without being
required (p = .001).
4.3.1

Independent Correlates of Self-reported Drug use During 12 Months Post-release
Results from the logistic regression model are presented in Table 4.2, indicating

significant associations between self-reported drug use post-release and factors at each
level of the social ecological model. At the intrapersonal (individual) level, compared to
women who did not report drug use during the 12-month follow-up period, women who
used drugs were younger (AOR = 0.97) and reported having been bothered by drug
problems on more days prior to incarceration (AOR = 1.02). They were also significantly
more likely to report experiencing mental health issues during the 12 months after
release, compared to women who had not used drugs during that time (AOR = 1.88).
At the interpersonal level, many factors that were significant in bivariate analyses
remained significant in the logistic regression model, after controlling for relevant
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covariates. Specifically, women who reported any drug use post-release were
significantly less likely to report having a close relationship with friends (AOR = 0.48),
having a 12-step fellowship sponsor (AOR = 0.40), and living with their minor children at
the time of the follow-up interview (AOR = 0.44). They were also less likely to report
spending most of their free time with family (versus with friends or alone; AOR = 0.49).
However, drug use was significantly associated with higher odds of having minor
children in someone else’s temporary legal custody (AOR = 1.83).
At the institutional level, past-30-day income from wages was significantly
associated with decreased odds of illicit drug use after release (AOR = 0.42). Post-hoc
estimates of fully standardized coefficients indicated that income from wages was
associated with the largest difference in odds of self-reported drug use, compared to all
other independent variables included in the model.
One factor was significant at the community level: namely, women who reported
any drug use post-release were significantly more likely to report attending self-help
group meetings (e.g., AA/NA) that were required as a condition of their parole or
probation, compared to women who did not attend any meetings (AOR = 1.98).
4.3.2

Qualitative Results
At the time of their 12-month follow-up interview, all women were asked, “what

factors are associated with those who are successful after treatment?” Thirteen
participants did not provide a substantive response (e.g., “I don’t know”) and were not
coded, resulting in 412 valid, coded responses. Women who reported illicit drug use
(38.4%; n=163) were also asked, “what would you say were the factors that led up to
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your drug use?” and n=149 provided valid responses. For each qualitative item, the
percentage of women who endorsed a factor at each social ecological level is presented,
as well as themes associated with each level and illustrative quotes (Table 4.3). Some
themes are noted as cross-cutting (i.e., identified in responses to both questions, presented
side-by-side in the table) while others were coded in one question only.
4.3.2.1 Individual-level factors
Individual-level factors were most frequently cited by women as important for
success after treatment (71.1% of participants) and as contributing to likelihood of drug
use (50.3% of women who did not remain abstinent). One cross-cutting theme was
confidence and readiness/motivation to change; as one woman said, “A person just has to
want to be successful. That's what it always comes down to.” However, women who had
used drugs post-release also gave responses that reflected a lack of confidence or
readiness (e.g., “Being dumb;” “Careless”). Another cross-cutting theme was coping
skills: women described post-treatment success in terms of healthy skills, such as selfawareness or resilience, whereas women who had used drugs often discussed their drug
use as a means of coping with negative emotions (e.g., stress, anxiety, or anger). Unique
to women discussing post-release drug use, some also described their individual-level
motivations as grounded in managing pain or other physical symptoms. Others discussed
using drugs for enjoyment or pleasure, highlighting the rewarding or reinforcing aspects
of drug use that can inspire cravings or a desire to use, even after a period of abstinence.
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4.3.2.2 Interpersonal-level factors
Fewer participants mentioned interpersonal or relational factors that they believed
contributed to success after treatment (21.8%) or to drug use (27.5%). Social support
emerged as the only cross-cutting theme at this social ecological level. Although a strong
system could be valuable for encouragement and assistance in times of need, a lack of
support – feeling lonely or disconnected – could contribute to a desire to use and/or
reduce incentives to remain abstinent. For post-treatment success, some women
discussed relationships with family/children as a key factor, whereas other women
mentioned the importance of sponsorship through 12-step fellowships as a critical oneon-one relationship. For factors contributing to drug use, women described relational
trauma – such as grief and loss, violence, and the pain of broken or damaged
relationships (e.g., with children) – that contributed to their desire to use drugs. Women
also noted the presence of specific other people who were using drugs contributing to
their use, such as a partner or family member who was actively using and/or offered them
drugs.
4.3.2.3 Institutional-level factors
Institutional-level factors were mentioned by the fewest number of participants as
contributing to post-treatment success (7.5%) or to drug use (14.1%). For both questions,
women mentioned the cross-cutting theme of employment as valuable for selfsufficiency, routine, and “staying busy” after treatment. However, some women
mentioned difficulties finding a job, or frustration and stress related to their work, as
contributing to their drug use post-release. For post-treatment success, women also cited
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the importance of continued treatment services, such as therapy, intensive outpatient
treatment, or medications for SUD. Women who had used drugs after release also
discussed criminal-legal system involvement as a factor, specifically community
supervision: women discussed using drugs due to being confused, frustrated, and
overwhelmed by parole or probation requirements, or using in celebration of completing
supervision.
4.3.2.4 Community-level factors
At the community level, 41.3% of women cited factors as important for success
after treatment, while 29.5% cited factors that had contributed to their drug use. For both
questions, women discussed the value of the community of recovery self-help groups,
including 12-step fellowship meetings. However, community factors were also framed
from a negative perspective in both questions, namely environmental triggers. The need
to avoid the “people, places, [and/or] things” that were associated with previous use was
mentioned as critical for participants’ success. Similarly, many women who used drugs
after release described their use as triggered by the return to a physical location, such as
an old neighborhood, or about the presence of drugs in their social environment. In
comparison to women who talked about a specific person that triggered use (whose
responses would be coded as “interpersonal”), women at the community level attributed
their drug use post-release to their broader social contexts: “being around people… who
were doing it.” Finally, women discussing post-treatment success also mentioned
belongingness to communities of religion/spirituality (e.g., church attendance) as
meaningful to them.

98

4.3.2.5 Comparing social ecological factors supporting success
by abstinence vs. drug use
Lastly, a series of chi-square tests were used to compare women who reported any
drug use and those who did not, by factors mentioned at each level of the question
regarding post-treatment success. No significant differences were observed at the
individual, institutional, or community level. However, women who reported any drug
use during the 12 months post-release were significantly less likely to mention
interpersonal factors for post-treatment success, compared to women who did not use
drugs (16.1% vs. 25.3%), χ2 (1, N = 412) = 4.8, p = .03.
4.3.3

Comparison of Quantitative and Qualitative Results
A convergent parallel, or “triangulation,” mixed methods study design involves

the collection of both quantitative and qualitative data for the purpose of direct
comparison of the results of both methods (Kettles et al., 2011). To that end, results from
quantitative and qualitative analyses were compared to more fully understand facilitating
and risk factors for women’s successful recovery post-release.
At the individual level, both quantitative and qualitative analysis supported the
significance of mental health issues or negative emotions as a factor associated with illicit
drug use. However, severity of “drug problems” at treatment entry, as well as women’s
age, were indicated as significant in the regression analysis but not discussed in openended response questions. Similarly, pain/physical ailments were identified in qualitative
analysis, but did not emerge as significant in the regression model. Qualitative analysis
also revealed several internal/individual factors that were not available in the quantitative
data, including resilience, confidence, and use of drugs for enjoyment or pleasure.
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Although few individual-level factors were significantly associated with drug use in
quantitative analysis, factors at this level were discussed by the greatest proportion of
participants in qualitative responses.
At the interpersonal level, many variables were significantly related to lower odds
of drug use after release, including relationships with family, friends, children, 12-step
sponsors, and other individuals who women identified as supportive of their recovery.
These same sources of social support were congruent with women’s qualitative responses
as well. However, discussing factors associated with drug use, women also identified
sources of relational strain, such as relationships with specific individuals who were
associated with active use (particularly current or former romantic partners) or
experiences of relational trauma (e.g., grief, loss, or betrayal). In the regression model,
custody loss of minor children was associated with drug use, also alluding to the negative
potential of women’s relationships. However, this complexity of interpersonal factors as
both positive and negative forces in women’s lives was more clearly identified through
qualitative analysis.
Employment at 12 months post-release (i.e., earnings from wages) was the only
quantitative variable significantly associated with post-release drug use at the institutional
level, though it had the largest standardized coefficient of any variable included in the
regression model. In comparison, institutional-level factors were discussed by very few
women in reference to success after treatment (7.5%) or as contributors to drug use
(14.1%), although the theme of employment was prevalent within these responses. In
addition to work, women talked about the value of engagement with treatment services
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and challenges with experiences on supervision in their open-ended responses, neither of
which emerged as significant in the regression model.
Finally, in quantitative analysis at the community level, required self-help group
meeting attendance was associated with increased likelihood of drug use, relative to
women who did not attend meetings. This unique finding was not replicated in
qualitative responses, in which group meetings were framed only as a supportive and
stabilizing influence, as were church communities or other religious groups (which were
not available in the quantitative dataset). However, women’s qualitative data provided
additional nuance and context by presenting community-level risks in the form of
environmental triggers, including returning to a former neighborhood or area associated
with use (i.e., “old people, places, and things”), or finding one’s self in a situation where
drugs were present (e.g., at work or in transitional housing).

4.4

Discussion
This paper is the first to provide a mixed-methods, social-ecological analysis of

the unique factors associated with abstinence from illicit drug use among women during
the critical transitional period of community reentry, which has important implications
for clinical and CLS contexts. The first aim examined independent correlates of illicit
drug use self-reported by women during a 12-month follow-up period after completion of
a corrections-based SUD treatment program and subsequent release from jail or prison.
Factors were considered separately at each level of the social ecological model. The fact
that distinct factors emerged as significant across all four social ecological levels (in both
bivariate and regression analyses) is evidence of the value of conceptualizing risk and
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protective factors from a multilevel theoretical perspective. Even interventions targeting
issues at a single level (e.g., individual or interpersonal) can acknowledge and
incorporate education related to the influence of multilevel factors on clients’ recovery
capital.
Many findings from the present study’s quantitative analysis have been replicated
in prior research with CLS-involved women. Younger age, greater problem severity at
treatment entry, and ongoing mental health issues have all been associated with increased
likelihood of a recurrence of drug use following treatment (Andersson et al., 2019; Flynn
et al., 2004). Similarly, at the interpersonal level, connection with supportive friends and
family has been associated with a lower likelihood of returning to use (Binswanger et al.,
2012), and research has indicated that many women find benefit from one-on-one
relationships with 12-step sponsors and other women in recovery (Rush, 2002).
Relationships with children may be especially salient for women: prior studies have
demonstrated that loss of child custody is related to increased likelihood of drug use
(Harp & Oser, 2018) and overdose (Thumath et al., 2021), while living with children and
fulfilling motherhood responsibilities may be a powerful motivator for women to
maintain abstinence (Adams et al., 2021).
At the institutional level, employment was also associated with lower odds of
drug use after release from incarceration and had the largest standardized coefficient of
any independent variable in the model, suggesting high relative explanatory importance
for the outcome of interest. This relationship has been observed repeatedly in prior
studies, in which researchers have posited that employment builds recovery capital and
structure, provides a path to prosocial relationships, and offers practical support (Kendall
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et al., 2018). However, the bidirectional influence of this association should be
acknowledged given the cross-sectional nature of the data, in that women who first
experience a recurrence of drug use may also later experience difficulty in obtaining and
maintaining employment. Similarly, the association between required 12-step meeting
attendance and increased odds of drug use may indicate that women who attend meetings
under a mandate or obligation may engage for only a brief time, or may not engage
meaningfully/purposefully, neither of which are related to sustained abstinence (Majer et
al., 2011; Moos & Moos, 2004). However, a return to drug use may also result in
required 12-step meeting attendance by probation or parole as an incremental
accountability measure (Tillson et al., 2022b). Additional longitudinal research is needed
to understand the directionality of these relationships.
The second aim of this study was to examine women’s self-reported barriers and
facilitating factors for abstinence, using qualitative analysis of open-ended interview
questions, in which women were asked 1) what factors they believed to be associated
with success after treatment, and 2) among those who reported drug use, what factors
they thought led up to their use of drugs. For both questions, most participants’
responses were coded as referencing a factor at the individual level. While these internal
factors may merely be more salient to women than external ones, this finding may also
reflect women’s treatment experiences in therapeutic communities (TCs) while
incarcerated. TC modalities emphasize personal responsibility and accountability under
the framework that “the individual is seen as primarily responsible for his or her disorder
and recovery… the problem is the person, not the drug” (p. 48, De Leon, 2000). While
ownership of behavior may emphasize women’s agency, these programs have been
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criticized in correctional contexts, especially for women and other marginalized groups
(McKim, 2017; Sue, 2019). Although acceptance of personal responsibility can empower
change, acknowledgement of the structural violence and disadvantage often experienced
by incarcerated women with a history of drug misuse or SUD, particularly at the
intersection of race or other marginalizing aspects of identity, may be a valuable addition
to corrections-based treatment curriculums.
At the interpersonal or relational level, similar proportions of women discussed
factors that contributed to success after treatment or to likelihood of drug use postrelease. However, data from each qualitative item highlight the complex, often
contradictory nature of women’s relationships. For success factors, women discussed
that positive relationships with family, children, 12-step sponsors, and other social
supports could be protective against drug use, consistent with prior research (Arditti &
Few, 2008; Brown & Bloom, 2009; Gobena et al., 2022; Kendall et al., 2018; Leverentz,
2014; Robbins et al., 2009; Rush, 2002). Women who did not report drug use were also
significantly more likely to identify a success factor at the interpersonal level than those
who reported any use, suggesting that these interpersonal supports were more salient to
women who remained abstinent. Nonetheless, women also identified ways in which
relationships (e.g., with current or former intimate partners) contributed to risk of use. In
some of these cases, drug use was further indicated as a means of coping with relational
trauma, such as grief, loss, separation, and betrayal of trust, themes which have been
highlighted in previous research as influencing women’s returns to drug use, or
escalations of ongoing use (Daniulaityte & Carlson, 2011; Mildrum Chana et al., 2021).
These opposing findings emphasize the complexity of relationships for CLS-involved
104

women with a history of drug misuse or SUD, the need for continued use of qualitative or
mixed methods to capture nuanced differences, and the utility of assessments that
accurately describe the social networks of women in the process of recovery (Kendall et
al., 2018).
Institutional linkages and supports (e.g., vocational services, navigation to
treatment, clinical care) are highly represented in intervention research for women with
SUD transitioning from incarceration (Edwards et al., 2022). However, institutionallevel factors were mentioned by the smallest proportions of women for both qualitative
questions, suggesting that factors at this level may not have been as salient to study
participants. Nonetheless, employment was discussed by women in response to both
questions, consistent with research that has shown the importance of employment in
supporting abstinence through building recovery capital (Sahker et al., 2019). Despite
these benefits, women in recovery from substance use seeking jobs may face barriers
with hiring, scheduling, and dissatisfaction with low-paying, entry level positions
(Sinakhone et al., 2019). Additionally, national data has shown that incarcerated women
are more likely than men to report not working prior to incarceration (Swavola et al.,
2016) and to remain unemployed after release (Couloute & Kopf, 2018), making
potential work requirements of community supervision all the more difficult and
stressful. These challenges are reflected in the qualitative responses of women who
indicated that work-related stress, including not finding a job, contributed to their drug
use. Similarly, feelings of being overwhelmed or defeated by requirements related to
probation/parole were cited by a few women as factors leading to drug use, congruent
with qualitative research identifying the “multiple and competing demands” on reentering
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women as “one of the most profound challenges” hindering success in the community
(Richie, 2001).
Lastly, community-level factors were the second-most prevalent level mentioned
by participants for both questions, with consistent responses. Women indicated that
abstinence was supported by affiliation with communities, including religious and
recovery communities (e.g., AA/NA). However, the ability to remain abstinent could be
threatened by environmental triggers, such as returning to live in an old neighborhood or
county or being around other individuals who were known to use drugs. Participants
frequently discussed the need to avoid old “people, places, and things,” a common phrase
in recovery self-help groups that has been observed in other qualitative studies of CLSinvolved women with behavioral health issues (Canada, 2013; Leverentz, 2010). In these
contexts, specific relationships to others were not mentioned; rather, drug use was
presented as a feature of the social environment, suggesting that mere exposure to use –
even without specific social ties to others engaged in use – may be enough to increase
cravings. However, the ability of women to avoid triggers or living environments where
drug use is present may be challenged if women lack sufficient social and material
resources (Binswanger et al., 2012). Although the preponderance of intervention
research for reentering women with SUD has focused on institutional-level systems and
resources to address functional needs (Edwards et al., 2022), the larger social
environment of women’s community-level factors should not be overlooked: a triggering
or stigmatizing community context, compared to a supportive and inclusive one, may still
overpower positive influences at other social ecological levels.
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The final aim of this study was to compare quantitative and qualitative factors
found to associate with any drug use after women’s release from jail or prison across all
social ecological levels. Many findings were consistent across both analyses, which
demonstrated the risks of untreated mental health issues; the value of supportive
relationships with friends, family, children, and 12-step sponsors; and the importance of
employment. Nonetheless, key differences also emerged. Women’s qualitative
responses offered a more nuanced explanation of individual-level factors (e.g., resilience,
confidence, motivation for change) and described interpersonal factors as complex,
incongruous forces in the recovery process. Consistent with prior research, women’s
relationships could have positive (Arditti & Few, 2008; Gobena et al., 2022; Rush, 2002)
and/or negative (Brown et al., 2015; Daniulaityte & Carlson, 2011; Mildrum Chana et al.,
2021) impacts on women’s recovery. These individual and relational factors were not
explicitly measured in quantitative survey items but suggest valuable areas of focus for
future reentry/recovery research. Quantitative results also indicated factors that were not
presented in women’s qualitative responses, such as younger age or greater severity of
drug problems at treatment entry, or which were not emphasized as strongly, such as
employment. The significance of these factors in the present study and prior research
(Andersson et al., 2019; Flynn et al., 2004; Kendall et al., 2018) validates their
importance, but it is critical to note that women in the present study were more likely to
attribute their drug use to internal qualities, emotional states, relationships, and
environmental triggers. Future research should examine whether these attributional
choices are gender-specific, if they are replicable in other populations, and to what extent
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they may be a product of women’s SUD treatment experiences in corrections-based TC
programs.
This study is subject to limitations. The use of data collected at a single
timepoint, 12 months following women’s release from jail or prison, precludes causal
inference. Furthermore, responses may be subject to recall bias, given that women were
asked to describe events occurring over a 12-month period following release from
incarceration, although previous research has indicated that this type of self-report data is
valid (Darke, 1998; Denis et al., 2012). Respondent burden and fatigue may also have
affected responses to qualitative questions, which were asked in the middle (drug use)
and very end (post-treatment success) of the interview. Additionally, results may not be
generalizable to other populations of CLS-involved women with a history of drug use,
given the unique nature of the present sample (incarcerated, primarily White and nonHispanic). In particular, the inclusion criteria that women must have graduated from
treatment limits generalizability and creates difficulty in separating the impact of
programming from that of social ecological variables of interest. The use of a
dichotomous outcome variable (any drug use vs. no drug use) may also provide an
oversimplified understanding of recovery processes and use trajectories, despite the
inclusion of qualitative data to triangulate and contextualize quantitative findings. Future
research should incorporate more nuanced measures of use severity, as well as
information about timing and order of use events, to develop a more detailed
understanding of women’s recovery pathways during reentry from incarceration.
Finally, the influence of factors at the broadest social ecological level, reflecting
changes in policy and other overarching social factors, could not be accurately measured
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given study limitations, although several changes occurred during the span of women’s
release dates (April 2016 – September 2021) and the 12-month post-release timeframes
that may have impacted likelihood of women’s drug use. For example, in August 2020,
the Kentucky DOC authorized Program Good Time Credit (PGTC) to incentivize SUD
treatment engagement by allowing individuals under supervision to earn time off their
court-ordered sentence and reduce their time under supervision by engaging in PGTCeligible treatment programs (Tillson et al., 2022b). This shift may have prompted more
participants to engage in ongoing treatment services after release, reducing likelihood of
a recurrence of drug use. Furthermore, through collaborative partnerships, the DOC has
also launched several recent employment and education initiatives, including a
streamlined educational service program (KY Skills U, January 2019) and a
transportation assistance pilot program (August 2020; Tillson et al., 2022b) that may have
reduced risk of drug use by building women’s recovery capital. Additionally, the
implementation of shutdowns and protective measures due to the COVID-19 pandemic in
March 2020 (Shreve, 2021) may have had a profound impact on women’s mental health
and access to treatment and recovery support resources (Avena et al., 2021; Hurley et al.,
2021; Staton et al., 2021). The impact of these temporal policy factors should be a focus
of future research.
Despite these limitations, the present study has made a valuable contribution by
examining factors associated with drug use after release for women who completed
corrections-based SUD treatment. By purposefully and simultaneously examining
variables across multiple social ecological levels, findings have contributed to a more
holistic understanding of women’s risk and protective factors. Future research should
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also take into consideration the potential intersectionality across variables at diverse
levels of social ecological influence. Furthermore, this study has taken a unique
approach by leveraging the social ecological framework to compare quantitative findings
with women’s qualitative assessments of what supported their success or led to their drug
use. Results from these comparative analyses provide a more nuanced understanding, not
just of objective relationships between factors and outcomes, but also women’s own
interpretation of recovery processes and retrospective meaning assigned to drug use
events. Future studies should also continue to utilize mixed methods research to inform
effective SUD interventions and women-centered treatment or recovery support options
that address known risk factors for recurrences of drug use, while also acknowledging
women’s unique narratives and subjective understanding of recovery processes.
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Table 4.1 Bivariate comparisons between women who self-reported drug use during 12
months post-release and those who did not (N = 425)
SelfNo drug reported
Total
use
any drug
(N =
(n = 262)
use
425)
(n = 163)
Intrapersonal (individual) level
Age at release (years; range 20-60)*
37.1
35.2
36.4
(8.3)
(8.0)
(8.2)
Race
White
92.3%
95.0%
93.3%
Black/African-American
3.9%
2.5%
3.4%
American Indian or Alaskan Native
0.4%
0.6%
0.5%
Asian or Pacific Islander
0.4%
0.0%
0.2%
Other or multiracial
3.1%
1.9%
2.6%
Ethnicity (% Hispanic/Latina)
0.4%
1.2%
0.7%
At treatment entry (baseline)…
Number of days experienced drug problems in 30
19.0
23.2
20.6
days PTI (range 0-30)**
(13.6)
(11.5)
(13.0)
Abstinence self-efficacy at treatment entry,
89.7%
77.3%
84.9%
moderate or very good***
At follow-up (12 months post-release)…
Chronic physical pain
67.9%
65.6%
67.0%
Any mental health issues***
58.0%
77.3%
65.4%
Cognitive difficulties***
25.6%
48.5%
34.4%
Serious depression***
26.3%
54.6%
37.2%
Serious anxiety or tension***
50.4%
69.9%
57.9%
At re-entry, needed help with anything?**
64.9%
78.5%
70.1%
Employment or job training*
16.1%
25.3%
19.6%
Substance use treatment/recovery supports***
23.0%
42.3%
30.4%
Mental health services***
35.6%
51.9%
41.8%
Medical care for physical health**
42.4%
55.8%
47.5%
Interpersonal level
Since release, had a close relationship with…
Romantic/sexual partners
66.0%
66.9%
66.4%
Friends**
82.4%
69.9%
77.7%
Family members (e.g., parents, siblings, other)
97.2%
87.1%
89.7%
Has a 12-step fellowship sponsor**
33.2%
19.6%
28.0%
Has any children under 18
67.9%
76.7%
71.3%
Living with their minor children at follow-up***
30.2%
15.3%
24.5%
Has minor children in someone else’s temporary
39.7%
57.7%
46.6%
custody***
Spent free time post-release with family (vs. friends
82.8%
61.4%
74.6%
or alone)***
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Table 4.1 (continued)
Participant felt “extremely” cared about/supported
by important people in their life***
Institutional level
Participated in educational/vocational program
Past 30-day earnings from…
Wages***
Public assistance
Disability
Illegal activity**
Received any treatment for mental, physical, or
SUD after release
SUD treatment**
Mental health treatment
Physical health treatment
Taken prescribed mental health medication*
SUD treatment history before incarceration
Number of lifetime convictions (range 0-100)
Corrections-based treatment setting: prison (vs. jail)
Length of incarceration in months (prior to
treatment entry; range 1-480)
On supervision since release
Community level
Self-help group meeting attendance in 12 months
post-release***
Did not attend meetings
Attended meetings, required by supervision
Attended meetings, not required
County of residence at time of follow-up interview
Non-metro (vs. metro)
Appalachian (vs. non-Appalachian)
*p≤.05, **p≤.01, ***p≤.001
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70.2%

44.8%

60.5%

17.2%

10.4%

14.6%

65.3%
32.4%
8.0%
0.4%

40.5%
33.7%
6.8%
4.3%

55.7%
32.9%
7.5%
1.9%

65.3%

73.6%

68.5%

17.9%
23.3%
50.0%
37.4%
78.6%
6.8
(10.3)
48.1%
23.4
(35.9)
91.6%

30.1%
28.2%
44.2%
49.1%
85.9%
7.4
(9.6)
39.9%
19.4
(21.5)
92.6%

22.6%
25.2%
47.8%
41.9%
81.4%
7.1
(10.1)
44.9%
21.9
(31.2)
92.0%

25.2%
30.5%
44.3%

23.9%
47.2%
28.8%

24.7%
36.9%
38.4%

48.9%
30.9%

50.9%
37.4%

49.7%
33.4%

Table 4.2 Independent correlates of self-reported drug use during 12 months post-release
(N = 425)
AOR
95% CI
SE
p-value
Intrapersonal (individual) level
Age at release (years; range 20-60)*
0.97
[0.93, 1.00]
0.02
0.035
Days experienced drug problems PTI*
1.02
[1.00, 1.04]
0.01
0.040
Moderate/very good abstinence self0.55
[0.29, 1.05]
0.18
0.070
efficacy at treatment entry
Any mental health issues at follow-up*
1.88
[1.09, 3.26]
0.53
0.024
Needed employment help at reentry
1.33
[0.71, 2.46]
0.42
0.371
Needed help with any health issues at
1.47
[0.84, 2.56]
0.42
0.177
reentry
Interpersonal level
Since release…
Has had close relationship with friends*
0.48
[0.27, 0.85]
0.14
0.012
Has a 12-step fellowship sponsor**
0.40
[0.22, 0.72]
0.12
0.002
Living with their minor children at follow0.44
[0.24, 0.83]
0.14
0.011
up**
Has minor children in someone else’s
1.83
[1.10, 3.04]
0.47
0.020
temporary custody*
Spent free time with family*
0.49
[0.28, 0.86]
0.14
0.012
Felt “extremely” cared about/supported
0.63
[0.38, 1.03]
0.16
0.066
Institutional level
Since release…
Past 30-day earnings from wages***
0.42
[0.26, 0.69]
0.11
0.001
Past 30-day earnings from nonlegal income
2.12
[0.22, 19.96]
2.42
0.512
Received SUD treatment after release
1.32
[0.74, 2.36]
0.39
0.340
Taken prescribed mental health medication
1.16
[0.70, 1.94]
0.30
0.563
Community level
Self-help group meeting attendance in 12
months post-releasea
Attended meetings, required by
0.66
1.99
[1.03, 3.82]
0.040
supervision*
Attended meetings, not required
0.69
[0.36, 1.32]
0.23
0.259
2
Pseudo R = 0.24
*p≤.05, **p≤.01, ***p≤.001
a
Self-help group meeting attendance reference group=no meetings attended.
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Table 4.3 Themes associated with success after treatment, or contributing to drug use post-release, at each social ecological level
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INDIVIDUAL
Post-treatment success (N=412)
Drug use post-release (N=149)
Confidence and readiness/motivation:
Lack of confidence or readiness/motivation:
“Willing to put in the work.”
“Careless.”
“It depends on you; either you want to stay clean, or you don't.”
“Because I’m an addict, I guess.”
“Having that drive to do something better.”
“Bad choices.”
“Be confident in yourself and know what you want and you can
“Being dumb.”
achieve it.”
“I got complacent.”
“Know that you can do it.”
Using drugs to cope (e.g., with stress, anxiety, anger):
Healthy internal coping skills (e.g., self-awareness, resilience):
“[Drug use] helps me with anxiety and puts my mind at ease.
“Just being aware of your thoughts and behaviors.”
Makes me feel happier and eases my depression.”
“Honesty - with yourself and others.”
“Depression and boredom.”
“Don’t get overwhelmed.”
“Being stressed out; not used to being out in everyday life anymore
“Accepting the problem and learning from it and moving forward.”
after being incarcerated for 1.5 years.”
Enjoyment or pleasure:
“Just for fun.”
“I was actually just bored. I had everything, I didn't need money, I
had a house and two cars… I just got bored one day.”
“I like to get high.”
Pain or other physical symptoms:
“I use it for pain.”
“I use it for my seizures.”
“It helps my anxiety and my pain, and it helps with my seizures -more of a medical choice for me.”
INTERPERSONAL
Post-treatment success (N=412)
Drug use post-release (N=149)
Lack of social support:
Social support system:
“Lack of support and feeling alone and disconnected from the
“Supportive and positive people that relate to you and know you.”
world.”
“Social support has been the best thing since I have been out; just
“I only had myself to talk to because I never leave the apartment. I
having people around you that want better for you and support
have my fiance, but I know he doesn't want to hear… he's never
you through it.”
been on drugs or anything like that.”

Table 4.3 (continued)
Relationships with family and children:
“For me it was my kids. That was the only thing I cared about. I
had never been away from them. They were my drive to fix their
broken home.”
“My support from my family. My family was so, so accepting of
me when I got out. My family has helped me so much,
emotionally, and then letting me stay with them.”
12-step sponsorship:
“Talk to your sponsor.”
“If you have a sponsor they can hold you accountable and call you
out for your own BS.”
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Relational trauma:
“The guy I was seeing passed away of an overdose.”
“My husband was cheating on me and did it in my face so I turned
back to what I knew.”
“Having my mom die in my arms.”
“Abuse.”

Post-treatment success (N=412)
Employment:
“Get a job.”
“Go to work and be in a routine.”
“A decent job.”

Presence of specific other people who were using drugs:
“My son's father came around and I started using with him.”
“I was in a relationship, and he had relapsed a couple times already,
and the third time I relapsed with him.”
INSTITUTIONAL
Drug use post-release (N=149)
Employment:
“I was aggravated and stressed about my job.”
“I couldn’t get a job.”
“Not finding work quick enough.”

Table 4.3 (continued)

Treatment services
“IOP [intensive outpatient].”
“Talking to a counselor.”
“I need a program designed to make me go to the doctor and go to
counseling.”
“[You] need a therapist who can keep you healthy.”

Criminal-legal system involvement:
“Being overwhelmed by PO and their expectations.”
“Misunderstanding of parole requirements.”
“I found out I wasn't going to get off parole until 2025 and I felt so
defeated and I just thought why try.”
COMMUNITY
Drug use post-release (N=149)
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Post-treatment success (N=412)
Recovery self-help groups:
“Getting plugged into the fellowship of AA and getting more
involved.”
“I would say staying connected in recovery programs and
meetings... Feeling comfortable with the fellowship of recovery.”

Not engaging with recovery self-help groups:
“Not attending meetings, and didn't get a sponsor.”
“Just hadn't gotten a sponsor, hadn't went to meetings.”

Environment (e.g., presence of drugs):
Avoiding environmental triggers:
“I moved back to my home county.”
“Never go around the same people, places, and things.”
“I knew I was gonna be around it. I know you have to change
“Not being around the wrong the wrong people and the wrong areas
people places and things, but I can't change those.”
has really helped me.”
“I started working 3rd shift and I was around people using it.”
“Gotta know your triggers and gotta stay away… those old places,
“I was in the old place and to me that is what I knew.”
people, and things get you into a lot of trouble.”
“Everyone at the halfway house was using it.”
Religion or spirituality:
“The Bible is the only thing that's stopped me from using, and
prayer.”
“Going to church.”
“The meetings help but church really helps me a lot.”

CHAPTER 5. CONCLUSIONS
Women’s trajectories into and away from drug use, addiction, and criminal-legal
system (CLS) involvement are complex, nonlinear, and impacted by factors and forces
across multiple levels of influence. Along these pathways are many events that mark
transitional opportunities: points at which women’s use patterns may escalate in severity
or risk (e.g., for mortality, disease transmission, or victimization), or which may
alternatively mark a turning point towards healthier behaviors. This dissertation research
aimed to examine three such transitional events or experiences in the lives of CLSinvolved women with a history of drug use, to explore associated outcomes and possible
avenues for intervention.

5.1

Summary
Chapter 2 (Paper #1) focused on a sample of incarcerated women with a history of

injection drug use (IDU) from rural Appalachia to explore women’s likelihood of having
provided injection initiation assistance (IIA) to other individuals who use drugs. In the
final logistic regression model, few features of women’s own IDU experiences were
independently associated with likelihood of providing IIA. However, women were more
likely to have provided IIA if they also self-reported a more severe profile of injection
drug use (i.e., greater variety of drugs injected and faster transitions from first drug use to
first injection to regular injection). Additionally, women who used drugs in settings with
more people present, and who rated their peers as high in criminality, were more likely to
have also provided IIA. These findings suggest that provision of IIA is associated with

more severe patterns of IDU, but also with features of women’s peer groups and social
drug use behaviors.
Chapter 3 (Paper #2) investigated overdose-related experiences (i.e., personally
experiencing overdose, witnessing overdose, and naloxone sourcing knowledge) as selfreported by women entering jail- or prison-based substance use treatment, using an
intersectional risk environment model. Factors at all three levels of the intersectional risk
environment were uniquely associated with each overdose-related variable of interest,
highlighting the value of multilevel frameworks. Specifically, witnessing and
experiencing overdoses were strongly associated with IDU, opioid use disorder, and
mental health issues, such as suicidality and post-traumatic stress disorder (PTSD)
symptoms. Knowing where to obtain naloxone was associated with awareness of other
treatment or harm reduction resources, as well as having become incarcerated more
recently. Additionally, results from the final logistic regression model indicated that the
relationship between witnessing overdose and PTSD was moderated by naloxone
sourcing knowledge, such that knowing where to obtain naloxone was associated with
lower odds of PTSD among women who had previously seen another person overdose.
Although cross-sectional, these results suggest that potential adverse emotional
consequences of being present during an overdose may be mitigated if women feel
prepared and empowered to respond, consistent with evidence-based approaches for
recovery from other forms of trauma (East & Roll, 2015; Fallot & Harris, 2002; MasinMoyer et al., 2022).
Chapter 4 (Paper #3) employed a mixed methods design to examine factors
associated with a return to drug use among women who had graduated from jail- or
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prison-based substance use treatment and been released to the community. Grounded in a
modified social ecological framework (e.g., McLeroy et al., 1988), findings from the final
logistic regression model indicated that employment (at the institutional level) had the
strongest relative association to abstinence at 12 months post-release, although many
interpersonal-level factors were also significant. However, findings from women’s
qualitative responses rarely cited institutional-level factors, and predominantly focused
on individual-level constructs (e.g., readiness/motivation, coping skills), with
community-level factors (e.g., environmental triggers) being the next-most commonly
discussed. Results provide a more nuanced understanding of the retrospective meaning
assigned by women to their recovery processes and demonstrate that these narratives may
not align with results from quantitative analyses.

5.2
5.2.1

Cross-cutting themes and implications
Women’s health challenges and barriers to successful recovery/reentry
It is critical to note that the samples of CLS-involved women who participated in

the present research reported myriad experiences that could challenge their ability to
sustain abstinence from drug use or achieve positive change in other areas of their lives.
In the year before jail or prison, over half of incarcerated women in treatment reported
experiencing serious depression or anxiety, one in five had experienced suicidal thoughts,
and 45.2% met criteria for PTSD (Paper 2). Twelve months after their release to the
community, about two thirds of women reported still experiencing chronic pain and/or
mental health issues, only 55.7% had received recent income from employment, and
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70.1% reported that they had experienced at least one need at reentry (i.e., health- or
employment-related; Paper 3).
Beyond the transitional events or experiences that were the focus of the three
papers, these secondary findings highlight significant underlying physical and mental
health issues faced by women with a history of drug use and CLS involvement (Bronson
& Berzofsky, 2017; James & Glaze, 2006; Lynch et al., 2011; Maruschak et al., 2016).
The challenges created by these issues are further compounded by structural and systemic
barriers faced by women at reentry (Flowers, 2010; Li, 2018), particularly in rural areas
(Behringer & Friedell, 2006; Edmond et al., 2015; Hartley, 2004), and the additional
intersectional marginalization of women who also belong to a racial/ethnic, gender,
and/or sexual minority group (German & Latkin, 2015; Heimer et al., 2022). The
prevalence of these issues among the present samples of women indicates a critical need
for research, advocacy, and resource allocation to support positive outcomes for women
during the recovery and reentry processes.
5.2.2

Relationships matter
Across all three papers, findings supported the importance of women’s

relationships with others. These relationships can act as negative influences: women’s
social environments can normalize risky drug use patterns and behaviors, reflected in the
strong association between witnessing and experiencing overdose (Paper 2).
Relationships can also be a source of emotional strain, triggering a return to drug use
after abstinence has been achieved, as evidenced by both quantitative data (i.e., child
custody loss) and qualitative data (e.g., women discussing how lack of social support,
relational trauma, or the presence of others using drugs precipitated a return to use) in
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Paper 3. However, relationships can also be a critical source of material and emotional
support for women, whether from family, friends, children, 12-step sponsors, or others
who support their recovery (Paper 3), as documented in prior research (Arditti & Few,
2008; Leverentz, 2014; Rush, 2002). Although triggering relationships or ties to others
who use drugs may create risk for continued or escalated patterns of drug use, supportive
relationships have the potential to increase women’s recovery capital and facilitate
positive change (Cleveland et al., 2021).
Women’s relationships can also shape behaviors more directly, through
knowledge transfer, as in the provision of IIA for individuals who wish to initiate IDU.
Although this type of knowledge transfer could be framed as a negative outcome, given
the risks associated with IDU (e.g., overdose or infectious disease transmission; Staton et
al., 2018a), such risks can be mitigated through teaching and demonstration of safe
techniques. Understanding that IIA provision is a relatively common practice (Gicquelais
et al., 2020), women who provide IIA can be empowered to share such knowledge with
those who receive assistance. Furthermore, empowering women with information to
reduce chances of negative outcomes may have additional benefits – for example, how
naloxone sourcing knowledge was related to lower odds of PTSD among women who
have witnessed an overdose (Paper 2). Women’s social networks can thus also be vectors
of critical information.
5.2.3

The influence of community on women’s health behaviors
The third cross-cutting theme noted was the importance of theoretical frameworks

that look beyond a single dimension of independent variables, particularly to highlight
the influence of factors at the community level. Although all three papers focused on
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events or health behaviors that could be primarily framed as occurring on the individual
level (e.g., IDU initiation, overdose, returning to drug use), results highlighted significant
associations with several higher-level factors. For example, abstinence from drug use
after release from jail or prison was associated with women’s institutional-level
resources, namely employment (Paper 3). Furthermore, odds of experiencing overdose
were uniquely higher among women from Appalachian regions, whereas knowledge of
where to obtain naloxone was associated with awareness of local treatment and harm
reduction resources, as well as recent receipt of medication-assisted treatment (MAT;
Paper 2), all variables related to women’s community environments.

Additionally,

these factors (and others) remained significant even after controlling for variance in
individual-level variables, highlighting their unique impact. Situating these key events or
behaviors in context of the community, institutional, and/or environmental factors that
frame them provides a more holistic understanding of when, why, and to whom they may
be most likely to occur. Although the picture provided is not yet complete – all papers
were limited by use of secondary data and variables which were not measured – research
organized by multilevel theories will continue to further our knowledge base and has the
potential to highlight novel community-level targets for intervention.
5.2.4

Empowering women to take action and effect change
The women who participated in the present research exhibited high potential as

both providers and targets for interventions based in harm reduction services or
education. Specifically, Paper 1 highlighted that, while actively using drugs, most
women are embedded in social networks of others who also use drugs: only 17.7% of
women reported only using drugs alone in the six months before jail and 40.1% reported
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having ever provided IIA to another person. This rate of IIA provision is higher than has
been observed in most previous studies among people who inject drugs (Gicquelais et al.,
2020) and may be unique to the rural, Appalachian context, but nonetheless suggests a
valuable opportunity. If women who inject drugs are trained in safe injection practices
and provided with access to sufficient quantities of injection equipment to allow for
secondary distribution, in situations where IIA is requested of them, knowledge and
sterile equipment can be shared. In rural regions or other areas where harm reduction
organizations may struggle to access individuals directly, such strategies can extend the
reach of services (Montaque et al., 2022).
In addition to enhancing access to harm reduction services, providing women with
the information, equipment, and authority to help others has the added benefit of
empowering women as knowledgeable, active, and agentic members of their
communities. This would not only have the potential to prevent or mitigate harms to
other community members (e.g., reversing overdose), but also to benefit women
themselves, as observed by the lower likelihood of PTSD among women who had
witnessed an overdose but knew where to obtain naloxone. Women who use drugs
experience layers of perceived and/or enacted stigma from society at large (Meyers et al.,
2021), in addition to the heteronormative, patriarchal dynamics observed within
communities of people who use drugs (Early & Grundetjern, 2022; Bourgois et al.,
2004). Initiatives to educate and equip women to provide harm reduction services could
reduce women’s sense of powerlessness, building confidence and self-efficacy.
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5.2.5

Listening to women’s perspectives in their own words
Although quantitative research has immense value to measure, compare, and

statistically evaluate associations between sets of variables and outcomes or events,
purely quantitative research can sometimes be said to raise more questions than it
answers. For example, findings from Paper 1 describing correlates of rural Appalachian
women’s prior provision of IIA, while novel and important, did not encompass
information such as women’s motivations for providing IIA and whether these
motivations vary by context, what language they use to describe the process, how women
feel about providing IIA, and so on. Also, as demonstrated in Paper 3, a participant’s
interpretation of cause-and-effect, meaning or importance assigned to events, and
narratives constructed around recovery processes may not align with findings from
quantitative research. Although not appropriate for all research questions, mixed
methods or qualitative methods (when applicable) can allow for more in-depth
exploration of research topics, giving participants greater freedom to share opinions or
observations and to use terminology that is comfortable or familiar to them.

5.3

Future research directions
Findings from all three papers indicated possible directions for future research.

Findings from Paper 1 could be developed into a multisite qualitative pilot study with
both rural and urban women who inject drugs to explore provision of IIA in more detail,
as well as provision of ongoing injection assistance (not just at the initiation event). This
research could also examine other drug-related helping or caring behaviors among
women who inject drugs (e.g., secondary syringe distribution, overdose reversal, drug124

sharing), particularly in context of women’s knowledge and use of harm reduction
services. These pilot data could then inform development of a novel peer-based women’s
harm reduction intervention.
Paper 2 highlighted the need for continued research to explore new avenues for
naloxone training and distribution, given that less than half of women entering prison- or
jail-based substance use disorder (SUD) treatment knew where to obtain the life-saving
medication. Prior research has documented reasons why individuals may not be
interested in obtaining naloxone, including stigma against people who use opioids or fear
of negative consequences from possessing naloxone (Bennett et al., 2020). Additional
research should develop educational resources and messaging campaigns that can target
these concerns more directly. Furthermore, the associations between witnessing or
experiencing overdose and serious mental health concerns (i.e., suicidality and PTSD)
indicate an urgent need for brief trauma interventions and mental health crisis services
that are tailored to the needs of women who use drugs. These services should be
accessible (e.g., 24-hour, phone- and/or web-based), low-barrier (e.g., not contingent
upon receipt of other treatment services), and developed through additional qualitative
research to determine how best to support women’s mental health needs.
Finally, findings from Paper 3 highlighted key differences between quantitative
and qualitative results exploring factors associated with women’s abstinence vs. a
recurrence of drug use, suggesting a need for additional mixed-methods research.
Longitudinal studies of women’s recovery/reentry processes could incorporate a semistructured qualitative interview protocol at regular timepoints, alongside quantitative
measures, to assess how women’s subjective understandings of facilitating or risk factors
125

change over time. Additionally, research should explore whether the primarily
internal/individual-level attributions observed in the present research are unique to
women (vs. men) or to the therapeutic community model of treatment (vs. other treatment
models, or individuals who achieve abstinence without treatment). Ideally, interventions
could be developed and implemented at the community level to address women’s
substance misuse-related issues prior to arrest or incarceration. However, for women
with a history of SUD or substance misuse and CLS involvement, access to a menu of
treatment and recovery support options – backed by research evidence – must be
available both during and after incarceration to facilitate success.

5.4

Conclusions
Women with CLS involvement who use drugs are a vulnerable demographic due

to intersectional stigma (Meyers et al., 2021); economic marginalization (Flowers, 2010;
Li, 2018); myriad co-occurring mental and physical health needs (Bronson & Berzofsky,
2017; James & Glaze, 2006; Maruschak et al., 2016); and extensive histories of trauma,
violence, and victimization (Lynch et al., 2011). However, this dissertation research has
also highlighted women as empowered and resilient, with a high potential and capacity
for change, intervention, and influence. The transitional events or experiences discussed
in the preceding papers are merely three timepoints in women’s complex pathways into
and away from drug use, addiction, and CLS involvement, and much work remains to
understand how best to support women’s recovery and reentry efforts. Further research,
advocacy, and service expansion in this area will reduce disparities and improve the
health and well-being of all women, families, and communities impacted by drug use.
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